{"data": [{"entities": {"urls": [{"start": 69, "end": 92, "url": "https://t.co/KAOiObyiCy", "expanded_url": "https://twitter.com/ucsdanes/status/1601063795941482497", "display_url": "twitter.com/ucsdanes/statu\u2026"}], "mentions": [{"start": 16, "end": 25, "username": "UCSDAnes", "id": "1542877210356330497"}, {"start": 56, "end": 68, "username": "AleckAmalia", "id": "1331336294828437504"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "quoted", "id": "1601063795941482497"}], "edit_history_tweet_ids": ["1601314763203829761"], "created_at": "2022-12-09T20:36:05.000Z", "conversation_id": "1601314763203829761", "text": "Awesome work by @UCSDAnes and the legendary Dr. Aleck!\n\n@AleckAmalia https://t.co/KAOiObyiCy", "lang": "en", "id": "1601314763203829761"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1601307741355913217"}], "edit_history_tweet_ids": ["1601307961770397696"], "created_at": "2022-12-09T20:09:03.000Z", "conversation_id": "1601307961770397696", "entities": {"mentions": [{"start": 3, "end": 18, "username": "mattwilson2287", "id": "45443577"}, {"start": 37, "end": 47, "username": "sabobillo", "id": "829364688018407425"}, {"start": 48, "end": 57, "username": "CwynKate", "id": "879789995053240321"}], "hashtags": [{"start": 69, "end": 84, "tag": "CNSprophylaxis"}]}, "text": "RT @mattwilson2287: Check out our (+ @sabobillo @CwynKate) review on #CNSprophylaxis in this year's educational book\nhttps://t.co/3eq1rMVIZ\u2026", "lang": "en", "id": "1601307961770397696"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1601301763319300096"}], "edit_history_tweet_ids": ["1601301938712125440"], "created_at": "2022-12-09T19:45:07.000Z", "conversation_id": "1601285083566161922", "in_reply_to_user_id": "824315782947631104", "entities": {"mentions": [{"start": 0, "end": 9, "username": "acweyand", "id": "824315782947631104"}]}, "text": "@acweyand Yes.  They are open 24 hours a day.  I plan for a late night session again tonight", "lang": "en", "id": "1601301938712125440"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1601301238536028160"}], "edit_history_tweet_ids": ["1601301419155288065"], "created_at": "2022-12-09T19:43:03.000Z", "conversation_id": "1601285083566161922", "in_reply_to_user_id": "824315782947631104", "entities": {"mentions": [{"start": 0, "end": 9, "username": "acweyand", "id": "824315782947631104"}]}, "text": "@acweyand Amazing", "lang": "en", "id": "1601301419155288065"}, {"entities": {"urls": [{"start": 100, "end": 123, "url": "https://t.co/HB3ggnspZN", "expanded_url": "https://ashpublications.org/hematology", "display_url": "ashpublications.org/hematology", "images": [{"url": "https://pbs.twimg.com/news_img/1601300750361333760/cCTjZZww?format=png&name=orig", "width": 520, "height": 675}, {"url": "https://pbs.twimg.com/news_img/1601300750361333760/cCTjZZww?format=png&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Hematology | American Society of Hematology", "description": "The Hematology ASH Education Program 2022 provides review articles from the Education Program at the 2022 ASH Annual Meeting. In this publication, each chapter relates to a different session presented at the meeting, spanning the spectrum from basic discovery and disease pathogenesis to the clinical application at the bedside. This activity is supported by educational grants from AstraZeneca; GlaxoSmithKline; Incyte Corp.; Jazz Pharmaceuticals, Inc.; Merck Sharp & Dohme Corp.; and Novartis Pharmaceuticals", "unwound_url": "https://ashpublications.org/hematology"}, {"start": 132, "end": 155, "url": "https://t.co/b1V2yZphMh", "expanded_url": "https://twitter.com/AaronGoodman33/status/1601300744644472832/photo/1", "display_url": "pic.twitter.com/b1V2yZphMh", "media_key": "3_1601300676432330754"}], "annotations": [{"start": 8, "end": 20, "probability": 0.6312, "type": "Other", "normalized_text": "ASH Education"}, {"start": 60, "end": 67, "probability": 0.4838, "type": "Person", "normalized_text": "Hannukah"}], "hashtags": [{"start": 125, "end": 131, "tag": "ASH22"}]}, "author_id": "854692626015993857", "edit_history_tweet_ids": ["1601300744644472832"], "created_at": "2022-12-09T19:40:22.000Z", "conversation_id": "1601300744644472832", "text": "Yes the ASH Education Book has been released!!!\n\nChristmas (Hannukah) is a little early this year!\n\nhttps://t.co/HB3ggnspZN\n\n#ASH22 https://t.co/b1V2yZphMh", "lang": "en", "id": "1601300744644472832"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1601259817154543616"}], "edit_history_tweet_ids": ["1601299217011847168"], "created_at": "2022-12-09T19:34:18.000Z", "conversation_id": "1601259817154543616", "in_reply_to_user_id": "918471705408016384", "entities": {"mentions": [{"start": 0, "end": 15, "username": "PallawiTorkaMD", "id": "918471705408016384"}, {"start": 16, "end": 28, "username": "RoswellPark", "id": "16044589"}, {"start": 29, "end": 43, "username": "RoswellHemOnc", "id": "1378011784674705409"}, {"start": 44, "end": 58, "username": "HemOncFellows", "id": "1357568654444003335"}, {"start": 59, "end": 73, "username": "msalmanfaisal", "id": "141154688"}]}, "text": "@PallawiTorkaMD @RoswellPark @RoswellHemOnc @HemOncFellows @msalmanfaisal Beautiful", "lang": "en", "id": "1601299217011847168"}, {"entities": {"urls": [{"start": 37, "end": 60, "url": "https://t.co/eVOSM6pkMP", "expanded_url": "https://twitter.com/AaronGoodman33/status/1601285083566161922/photo/1", "display_url": "pic.twitter.com/eVOSM6pkMP", "media_key": "3_1601285077639602178"}], "annotations": [{"start": 1, "end": 5, "probability": 0.6663, "type": "Other", "normalized_text": "ASH22"}], "mentions": [{"start": 26, "end": 35, "username": "acweyand", "id": "824315782947631104"}], "hashtags": [{"start": 0, "end": 6, "tag": "ASH22"}]}, "author_id": "854692626015993857", "edit_history_tweet_ids": ["1601285083566161922"], "created_at": "2022-12-09T18:38:09.000Z", "conversation_id": "1601285083566161922", "text": "#ASH22\n\nThese look good!\n\u2066@acweyand\u2069 https://t.co/eVOSM6pkMP", "lang": "en", "id": "1601285083566161922"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1601170628899323904"}], "edit_history_tweet_ids": ["1601268229288382465"], "created_at": "2022-12-09T17:31:10.000Z", "conversation_id": "1601268229288382465", "entities": {"annotations": [{"start": 130, "end": 131, "probability": 0.7554, "type": "Place", "normalized_text": "US"}], "mentions": [{"start": 3, "end": 15, "username": "HadidiSamer", "id": "774267564"}], "hashtags": [{"start": 64, "end": 70, "tag": "ASH22"}, {"start": 107, "end": 112, "tag": "mmsm"}]}, "text": "RT @HadidiSamer: Let\u2019s look at 2 smoldering MM trials presented #ASH22 of from different(important) angles #mmsm \ud83e\uddf5\n\nASCENT trial (US)\nGEM-C\u2026", "lang": "en", "id": "1601268229288382465"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1601119499625041923"}], "edit_history_tweet_ids": ["1601119636615221249"], "created_at": "2022-12-09T07:40:43.000Z", "conversation_id": "1601119636615221249", "entities": {"annotations": [{"start": 127, "end": 131, "probability": 0.5093, "type": "Other", "normalized_text": "ash22"}, {"start": 134, "end": 138, "probability": 0.486, "type": "Other", "normalized_text": "ash20"}], "mentions": [{"start": 3, "end": 16, "username": "VPrasadMDMPH", "id": "1194962714"}, {"start": 71, "end": 86, "username": "AaronGoodman33", "id": "854692626015993857"}], "hashtags": [{"start": 126, "end": 132, "tag": "ash22"}]}, "text": "RT @VPrasadMDMPH: So nice to top the impressions \ud83d\ude0a alongside the great @AaronGoodman33\nI will be releasing videos all through #ash22 #ash20\u2026", "lang": "en", "id": "1601119636615221249"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1601115768598712322"}], "edit_history_tweet_ids": ["1601116932937506816"], "created_at": "2022-12-09T07:29:58.000Z", "conversation_id": "1601116932937506816", "entities": {"mentions": [{"start": 3, "end": 13, "username": "ASkarbnik", "id": "999010996034338818"}, {"start": 45, "end": 60, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 61, "end": 73, "username": "GuiperiniMD", "id": "1294745239656202240"}, {"start": 74, "end": 86, "username": "matthew_mei", "id": "354168091"}, {"start": 87, "end": 99, "username": "smalveira23", "id": "1125437852836175874"}, {"start": 100, "end": 112, "username": "chadinabhan", "id": "2212735524"}]}, "text": "RT @ASkarbnik: In real life we\u2019re friends \ud83d\ude09 \n@AaronGoodman33 @GuiperiniMD @matthew_mei @smalveira23 @chadinabhan where are you? https://t.c\u2026", "lang": "en", "id": "1601116932937506816"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1601098351755558913"}], "edit_history_tweet_ids": ["1601109066184798210"], "created_at": "2022-12-09T06:58:43.000Z", "conversation_id": "1601084075368124416", "in_reply_to_user_id": "215681001", "entities": {"mentions": [{"start": 0, "end": 13, "username": "allisonp1979", "id": "215681001"}]}, "text": "@allisonp1979 6 AM to early.  I can do 9 Am same pace ?", "lang": "en", "id": "1601109066184798210"}, {"author_id": "854692626015993857", "edit_history_tweet_ids": ["1601084075368124416"], "created_at": "2022-12-09T05:19:24.000Z", "conversation_id": "1601084075368124416", "text": "#ASH22\n\nAnyone in New Orleans want to go on a run tomorrow morning?", "entities": {"hashtags": [{"start": 0, "end": 6, "tag": "ASH22"}]}, "lang": "en", "id": "1601084075368124416"}, {"entities": {"urls": [{"start": 144, "end": 167, "url": "https://t.co/g3Rf86gPJ3", "expanded_url": "https://twitter.com/papaemmanuillab/status/1600254596235960320", "display_url": "twitter.com/papaemmanuilla\u2026"}], "hashtags": [{"start": 0, "end": 6, "tag": "ASH22"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "quoted", "id": "1600254596235960320"}], "edit_history_tweet_ids": ["1601056656691187712"], "created_at": "2022-12-09T03:30:27.000Z", "conversation_id": "1601056656691187712", "text": "#ASH22\n\nTomorrow At 2 PM excited to learn some pathology and the new classification for blood cancer.  Everyone should come better than soccer. https://t.co/g3Rf86gPJ3", "lang": "en", "id": "1601056656691187712"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1601036828194533377"}], "edit_history_tweet_ids": ["1601054516828606465"], "created_at": "2022-12-09T03:21:57.000Z", "conversation_id": "1601020396685660160", "in_reply_to_user_id": "1334487799718961153", "entities": {"mentions": [{"start": 0, "end": 14, "username": "MartinTallman", "id": "1334487799718961153"}, {"start": 15, "end": 27, "username": "chadinabhan", "id": "2212735524"}, {"start": 28, "end": 40, "username": "romeerizwan", "id": "15622046"}, {"start": 41, "end": 54, "username": "BldCancerDoc", "id": "2809497047"}, {"start": 55, "end": 66, "username": "ninashah33", "id": "1559241414"}, {"start": 67, "end": 78, "username": "Mohty_EBMT", "id": "2626263112"}, {"start": 79, "end": 94, "username": "JohnPLeonardMD", "id": "2891662867"}]}, "text": "@MartinTallman @chadinabhan @romeerizwan @BldCancerDoc @ninashah33 @Mohty_EBMT @JohnPLeonardMD I disagree", "lang": "en", "id": "1601054516828606465"}, {"entities": {"urls": [{"start": 88, "end": 111, "url": "https://t.co/Hrwtu1vjVd", "expanded_url": "https://twitter.com/AaronGoodman33/status/1601052343071539200/photo/1", "display_url": "pic.twitter.com/Hrwtu1vjVd", "media_key": "3_1601052337514201089"}], "annotations": [{"start": 27, "end": 33, "probability": 0.6896, "type": "Other", "normalized_text": "myeloid"}], "mentions": [{"start": 44, "end": 57, "username": "sanamloghavi", "id": "3076847052"}, {"start": 61, "end": 77, "username": "PapaemmanuilLab", "id": "3154223927"}], "hashtags": [{"start": 81, "end": 87, "tag": "ASH22"}]}, "author_id": "854692626015993857", "edit_history_tweet_ids": ["1601052343071539200"], "created_at": "2022-12-09T03:13:19.000Z", "conversation_id": "1601052343071539200", "text": "Look who I ran into my two myeloid hero\u2019s!\n\u2066@sanamloghavi\u2069 \n\u2066@PapaemmanuilLab\u2069 \n\n#ASH22 https://t.co/Hrwtu1vjVd", "lang": "en", "id": "1601052343071539200"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1601008586108174336"}], "edit_history_tweet_ids": ["1601051473642631175"], "created_at": "2022-12-09T03:09:52.000Z", "conversation_id": "1601051473642631175", "entities": {"mentions": [{"start": 3, "end": 10, "username": "KMirza", "id": "28108352"}], "hashtags": [{"start": 32, "end": 38, "tag": "ASH22"}, {"start": 129, "end": 139, "tag": "PathAtASH"}]}, "text": "RT @KMirza: &gt;56M impressions #ASH22 and it doesn't even officially start till Saturday! \ud83d\ude4c\ud83c\udffb\ud83d\ude4c\ud83c\udffb\n\nLooking forward to representing #PathAtASH so\u2026", "lang": "en", "id": "1601051473642631175"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600958272709988352"}], "edit_history_tweet_ids": ["1601001423864737795"], "created_at": "2022-12-08T23:50:59.000Z", "conversation_id": "1600958272709988352", "in_reply_to_user_id": "1194962714", "entities": {"mentions": [{"start": 0, "end": 13, "username": "VPrasadMDMPH", "id": "1194962714"}]}, "text": "@VPrasadMDMPH I think our OncLive abstract would take home gold!", "lang": "en", "id": "1601001423864737795"}, {"entities": {"urls": [{"start": 59, "end": 82, "url": "https://t.co/376FQxGYSb", "expanded_url": "https://twitter.com/draevens/status/1600982180507049984", "display_url": "twitter.com/draevens/statu\u2026"}], "annotations": [{"start": 39, "end": 46, "probability": 0.435, "type": "Other", "normalized_text": "Dr Evens"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "quoted", "id": "1600982180507049984"}], "edit_history_tweet_ids": ["1600982610347720705"], "created_at": "2022-12-08T22:36:13.000Z", "conversation_id": "1600982610347720705", "text": "I\u2019m here!  Great to meet the legendary Dr Evens in person. https://t.co/376FQxGYSb", "lang": "en", "id": "1600982610347720705"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1600893983668207617"}], "edit_history_tweet_ids": ["1600982404508057600"], "created_at": "2022-12-08T22:35:24.000Z", "conversation_id": "1600982404508057600", "entities": {"mentions": [{"start": 3, "end": 12, "username": "DrAEvens", "id": "719175246050410496"}, {"start": 14, "end": 26, "username": "chadinabhan", "id": "2212735524"}, {"start": 57, "end": 72, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "text": "RT @DrAEvens: @chadinabhan w/ unadulterated man crush on @AaronGoodman33?", "lang": "en", "id": "1600982404508057600"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600933603541942272"}], "edit_history_tweet_ids": ["1600981285937127425"], "created_at": "2022-12-08T22:30:58.000Z", "conversation_id": "1600865250374361089", "in_reply_to_user_id": "2212735524", "entities": {"mentions": [{"start": 0, "end": 12, "username": "chadinabhan", "id": "2212735524"}, {"start": 13, "end": 22, "username": "montypal", "id": "24660850"}, {"start": 23, "end": 31, "username": "Nirvana", "id": "68412310"}, {"start": 32, "end": 42, "username": "ASkarbnik", "id": "999010996034338818"}, {"start": 43, "end": 49, "username": "sghmd", "id": "53395744"}, {"start": 50, "end": 62, "username": "DocsWhoRock", "id": "1266013486376726528"}, {"start": 63, "end": 75, "username": "AleckAmalia", "id": "1331336294828437504"}, {"start": 76, "end": 88, "username": "DrRanaMcKay", "id": "1113559627809996801"}]}, "text": "@chadinabhan @montypal @Nirvana @ASkarbnik @sghmd @DocsWhoRock @AleckAmalia @DrRanaMcKay I would say super", "lang": "en", "id": "1600981285937127425"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600953322940551168"}], "edit_history_tweet_ids": ["1600953891725529088"], "created_at": "2022-12-08T20:42:06.000Z", "conversation_id": "1600851981702410240", "in_reply_to_user_id": "149477915", "entities": {"mentions": [{"start": 0, "end": 11, "username": "Haemophage", "id": "149477915"}, {"start": 12, "end": 27, "username": "ASH_hematology", "id": "84072624"}]}, "text": "@Haemophage @ASH_hematology I promise to drink them all", "lang": "en", "id": "1600953891725529088"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1600907726443323392"}], "edit_history_tweet_ids": ["1600909927718928384"], "created_at": "2022-12-08T17:47:24.000Z", "conversation_id": "1600909927718928384", "entities": {"annotations": [{"start": 135, "end": 137, "probability": 0.6784, "type": "Other", "normalized_text": "MRD"}], "mentions": [{"start": 3, "end": 16, "username": "VPrasadMDMPH", "id": "1194962714"}]}, "text": "RT @VPrasadMDMPH: Cure means, after a fixed course of therapy, you have the same survival as age sex matched controls\n\nIt doesn't mean MRD\u2026", "lang": "en", "id": "1600909927718928384"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600893983668207617"}], "edit_history_tweet_ids": ["1600900892298907648"], "created_at": "2022-12-08T17:11:30.000Z", "conversation_id": "1600893983668207617", "in_reply_to_user_id": "719175246050410496", "entities": {"mentions": [{"start": 0, "end": 9, "username": "DrAEvens", "id": "719175246050410496"}, {"start": 10, "end": 22, "username": "chadinabhan", "id": "2212735524"}]}, "text": "@DrAEvens @chadinabhan Jealous?", "lang": "fr", "id": "1600900892298907648"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600882405812113408"}], "edit_history_tweet_ids": ["1600885699447619584"], "created_at": "2022-12-08T16:11:08.000Z", "conversation_id": "1600882405812113408", "in_reply_to_user_id": "53395744", "entities": {"mentions": [{"start": 0, "end": 6, "username": "sghmd", "id": "53395744"}]}, "text": "@sghmd I\u2019m hitting the gym when I get there this afternoon!  I\u2019ll need to borrow your protein powder", "lang": "en", "id": "1600885699447619584"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600881552837091328"}], "edit_history_tweet_ids": ["1600884532932071426"], "created_at": "2022-12-08T16:06:30.000Z", "conversation_id": "1600865250374361089", "in_reply_to_user_id": "3497730012", "entities": {"mentions": [{"start": 0, "end": 10, "username": "barttels2", "id": "3497730012"}, {"start": 11, "end": 23, "username": "chadinabhan", "id": "2212735524"}, {"start": 24, "end": 32, "username": "Nirvana", "id": "68412310"}, {"start": 33, "end": 43, "username": "ASkarbnik", "id": "999010996034338818"}, {"start": 44, "end": 50, "username": "sghmd", "id": "53395744"}, {"start": 51, "end": 63, "username": "DocsWhoRock", "id": "1266013486376726528"}, {"start": 64, "end": 73, "username": "montypal", "id": "24660850"}, {"start": 74, "end": 86, "username": "AleckAmalia", "id": "1331336294828437504"}, {"start": 87, "end": 99, "username": "DrRanaMcKay", "id": "1113559627809996801"}]}, "text": "@barttels2 @chadinabhan @Nirvana @ASkarbnik @sghmd @DocsWhoRock @montypal @AleckAmalia @DrRanaMcKay Strong words.  STP music was extremely original.", "lang": "en", "id": "1600884532932071426"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1600868817608925184"}], "edit_history_tweet_ids": ["1600869365641248775"], "created_at": "2022-12-08T15:06:14.000Z", "conversation_id": "1600869365641248775", "entities": {"annotations": [{"start": 33, "end": 35, "probability": 0.5955, "type": "Other", "normalized_text": "MRD"}, {"start": 51, "end": 55, "probability": 0.6588, "type": "Other", "normalized_text": "ASH22"}, {"start": 94, "end": 96, "probability": 0.6378, "type": "Other", "normalized_text": "MRD"}], "mentions": [{"start": 3, "end": 12, "username": "ManniMD1", "id": "1269642863924609025"}], "hashtags": [{"start": 50, "end": 56, "tag": "ASH22"}]}, "text": "RT @ManniMD1: As you prepare for MRD abstracts at #ASH22, here is our paper that explains how MRD has been used in the last 5 years of #mms\u2026", "lang": "en", "id": "1600869365641248775"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1600865250374361089"}], "edit_history_tweet_ids": ["1600866504295084032"], "created_at": "2022-12-08T14:54:51.000Z", "conversation_id": "1600866504295084032", "entities": {"annotations": [{"start": 72, "end": 75, "probability": 0.4123, "type": "Organization", "normalized_text": "PAPA"}], "mentions": [{"start": 3, "end": 15, "username": "chadinabhan", "id": "2212735524"}, {"start": 77, "end": 92, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 117, "end": 125, "username": "Nirvana", "id": "68412310"}], "hashtags": [{"start": 21, "end": 42, "tag": "HealthcareUnfiltered"}]}, "text": "RT @chadinabhan: The #HealthcareUnfiltered podcast crashed the party at PAPA @AaronGoodman33 house 2 talk guitar and @Nirvana \nThere was NO\u2026", "lang": "en", "id": "1600866504295084032"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600854069664366592"}], "edit_history_tweet_ids": ["1600854504865341440"], "created_at": "2022-12-08T14:07:11.000Z", "conversation_id": "1600850247185354752", "in_reply_to_user_id": "1144997352148787201", "entities": {"mentions": [{"start": 0, "end": 14, "username": "Dr_AmerZeidan", "id": "1144997352148787201"}]}, "text": "@Dr_AmerZeidan awesome", "lang": "en", "id": "1600854504865341440"}, {"entities": {"urls": [{"start": 188, "end": 211, "url": "https://t.co/IoYWmTnGp6", "expanded_url": "https://twitter.com/AaronGoodman33/status/1600851981702410240/photo/1", "display_url": "pic.twitter.com/IoYWmTnGp6", "media_key": "3_1600851694492991488"}], "annotations": [{"start": 52, "end": 64, "probability": 0.6663, "type": "Other", "normalized_text": "ASH Education"}, {"start": 98, "end": 108, "probability": 0.9897, "type": "Place", "normalized_text": "New Orleans"}, {"start": 122, "end": 132, "probability": 0.9898, "type": "Place", "normalized_text": "New Orleans"}], "mentions": [{"start": 9, "end": 24, "username": "ASH_hematology", "id": "84072624"}], "hashtags": [{"start": 0, "end": 6, "tag": "ASH22"}]}, "author_id": "854692626015993857", "edit_history_tweet_ids": ["1600851981702410240"], "created_at": "2022-12-08T13:57:09.000Z", "conversation_id": "1600851981702410240", "text": "#ASH22 \n\n@ASH_hematology has 2 hours to release the ASH Education book before I board my plane to New Orleans.\n\nAnyone in New Orleans tonight want to get a beer and talk hematology DM me. https://t.co/IoYWmTnGp6", "lang": "en", "id": "1600851981702410240"}, {"entities": {"urls": [{"start": 215, "end": 238, "url": "https://t.co/ahkx3EXP79", "expanded_url": "https://tinyurl.com/mrxjmfcx", "display_url": "tinyurl.com/mrxjmfcx", "images": [{"url": "https://pbs.twimg.com/news_img/1600850252679913473/WC5zZrIZ?format=jpg&name=orig", "width": 1200, "height": 630}, {"url": "https://pbs.twimg.com/news_img/1600850252679913473/WC5zZrIZ?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Quantifying the Erlenmeyer flask deformity. | Semantic Scholar", "description": "Unlike diagnostic assignments based on subjective review, this simple procedure for identifying the modelling deformity is based on robust quantitative measurement and should facilitate comparative studies between different groups of patients, and may allow more rigorous exploration of the pathogenesis of the complex osseous manifestations of Gaucher's disease to be undertaken. OBJECTIVE Erlenmeyer flask deformity is a common radiological finding in patients with Gaucher's disease; however, no definition of this deformity exists and the reported prevalence of the deformity varies widely. To devise an easily applied definition of this deformity, we investigated a cohort of knee radiographs in which there was consensus between three experienced radiologists as to the presence or absence of Erlenmeyer flask morphology. METHODS Using the presence or absence of Erlenmeyer flask morphology as a benchmark, we measured the diameter of the femur at the level of the physeal scar and serially at ", "unwound_url": "https://www.semanticscholar.org/paper/Quantifying-the-Erlenmeyer-flask-deformity.-Carter-Rajan/122771e4483466e411ef812b8344761f1109aad1"}, {"start": 239, "end": 262, "url": "https://t.co/Kj7amRys98", "expanded_url": "https://twitter.com/AaronGoodman33/status/1600850247185354752/photo/1", "display_url": "pic.twitter.com/Kj7amRys98", "media_key": "3_1600850110845427712"}], "annotations": [{"start": 20, "end": 31, "probability": 0.5439, "type": "Other", "normalized_text": "splenomegaly"}, {"start": 37, "end": 48, "probability": 0.5797, "type": "Other", "normalized_text": "pancytopenia"}]}, "author_id": "854692626015993857", "edit_history_tweet_ids": ["1600850247185354752"], "created_at": "2022-12-08T13:50:15.000Z", "conversation_id": "1600850247185354752", "text": "An unusual cause of splenomegaly and pancytopenia  in an adult!\n\nThink back to chemistry class and look at that femur...\n\nI have seen a few of these so yes you need to know it.  And yes this can present in adults!\n\nhttps://t.co/ahkx3EXP79 https://t.co/Kj7amRys98", "lang": "en", "id": "1600850247185354752"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600695160878223360"}], "edit_history_tweet_ids": ["1600697417061781504"], "created_at": "2022-12-08T03:42:58.000Z", "conversation_id": "1600685500339171330", "in_reply_to_user_id": "1269642863924609025", "entities": {"mentions": [{"start": 0, "end": 9, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 10, "end": 20, "username": "HiraSMian", "id": "419595308"}]}, "text": "@ManniMD1 @HiraSMian Epic in box empty no more clinic.   Don\u2019t be jealous.", "lang": "en", "id": "1600697417061781504"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600694442427502594"}], "edit_history_tweet_ids": ["1600694917885743104"], "created_at": "2022-12-08T03:33:02.000Z", "conversation_id": "1600642889280798721", "in_reply_to_user_id": "1194962714", "entities": {"mentions": [{"start": 0, "end": 13, "username": "VPrasadMDMPH", "id": "1194962714"}, {"start": 14, "end": 28, "username": "MichaelJSlade", "id": "626650397"}, {"start": 29, "end": 43, "username": "CyclingDoctor", "id": "23036480"}, {"start": 44, "end": 56, "username": "LabFehniger", "id": "1198731683199098881"}, {"start": 57, "end": 69, "username": "DiPersioLab", "id": "1349142172415762433"}, {"start": 70, "end": 79, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 80, "end": 94, "username": "DavidSteensma", "id": "2739065578"}, {"start": 95, "end": 105, "username": "bdermanmd", "id": "872983600416862208"}, {"start": 106, "end": 116, "username": "VincentRK", "id": "24261916"}, {"start": 117, "end": 127, "username": "myelomaMD", "id": "301568235"}, {"start": 128, "end": 137, "username": "Geoff_Uy", "id": "985139345928736768"}]}, "text": "@VPrasadMDMPH @MichaelJSlade @CyclingDoctor @LabFehniger @DiPersioLab @ManniMD1 @DavidSteensma @bdermanmd @VincentRK @myelomaMD @Geoff_Uy Obviously", "lang": "en", "id": "1600694917885743104"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600642889280798721"}], "edit_history_tweet_ids": ["1600690511395758081"], "created_at": "2022-12-08T03:15:31.000Z", "conversation_id": "1600642889280798721", "entities": {"annotations": [{"start": 325, "end": 337, "probability": 0.6394, "type": "Other", "normalized_text": "histiocytosis"}, {"start": 401, "end": 407, "probability": 0.9501, "type": "Other", "normalized_text": "Twitter"}], "mentions": [{"start": 0, "end": 14, "username": "MichaelJSlade", "id": "626650397"}, {"start": 15, "end": 29, "username": "CyclingDoctor", "id": "23036480"}, {"start": 30, "end": 42, "username": "LabFehniger", "id": "1198731683199098881"}, {"start": 43, "end": 55, "username": "DiPersioLab", "id": "1349142172415762433"}, {"start": 56, "end": 65, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 66, "end": 80, "username": "DavidSteensma", "id": "2739065578"}, {"start": 81, "end": 91, "username": "bdermanmd", "id": "872983600416862208"}, {"start": 92, "end": 105, "username": "VPrasadMDMPH", "id": "1194962714"}, {"start": 106, "end": 116, "username": "VincentRK", "id": "24261916"}, {"start": 117, "end": 127, "username": "myelomaMD", "id": "301568235"}, {"start": 128, "end": 137, "username": "Geoff_Uy", "id": "985139345928736768"}]}, "in_reply_to_user_id": "626650397", "text": "@MichaelJSlade @CyclingDoctor @LabFehniger @DiPersioLab @ManniMD1 @DavidSteensma @bdermanmd @VPrasadMDMPH @VincentRK @myelomaMD @Geoff_Uy For main heme malignancies i go through the clinical results categories for oral abstracts and read ones that stand out/may alter practice.\n\nFor clinical interests (t cell/skin lymphoma, histiocytosis) I review all oral abstracts (usually not many).\n\nLeave it to Twitter for rest!", "lang": "en", "id": "1600690511395758081"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600655843313213440"}], "edit_history_tweet_ids": ["1600673506965868544"], "created_at": "2022-12-08T02:07:57.000Z", "conversation_id": "1600655843313213440", "in_reply_to_user_id": "537795028", "entities": {"mentions": [{"start": 0, "end": 10, "username": "JReinerMD", "id": "537795028"}]}, "text": "@JReinerMD Yes mask at the meeting but take off at the after party at the bar.", "lang": "en", "id": "1600673506965868544"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600617014053183491"}], "edit_history_tweet_ids": ["1600654832171294721"], "created_at": "2022-12-08T00:53:45.000Z", "conversation_id": "1600519646028869633", "entities": {"annotations": [{"start": 250, "end": 252, "probability": 0.3819, "type": "Organization", "normalized_text": "ASH"}], "mentions": [{"start": 0, "end": 9, "username": "JKanerMD", "id": "782764410"}, {"start": 10, "end": 24, "username": "Dr_AmerZeidan", "id": "1144997352148787201"}]}, "in_reply_to_user_id": "782764410", "text": "@JKanerMD @Dr_AmerZeidan The 60 vs 90 question was never answered definitively in my opinion. I much prefer these studies then numerous redundant phase 2 studies that usually don\u2019t even reinforce my practice.  Both of you I look forward to seeing at ASH", "lang": "en", "id": "1600654832171294721"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600545405540126720"}], "edit_history_tweet_ids": ["1600546340873781248"], "created_at": "2022-12-07T17:42:39.000Z", "conversation_id": "1600545405540126720", "in_reply_to_user_id": "1269642863924609025", "entities": {"mentions": [{"start": 0, "end": 9, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 10, "end": 18, "username": "iStopMM", "id": "844232399319941122"}, {"start": 19, "end": 33, "username": "sykristinsson", "id": "3078258341"}]}, "text": "@ManniMD1 @iStopMM @sykristinsson can you send me the talk?", "lang": "en", "id": "1600546340873781248"}, {"entities": {"urls": [{"start": 256, "end": 279, "url": "https://t.co/pQ1sZbIV0g", "expanded_url": "https://tinyurl.com/bdcm7u8t", "display_url": "tinyurl.com/bdcm7u8t", "status": 200, "title": "Paper: Single Versus Double Induction with \u201c7+3\u201d Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial", "description": "Program: Oral and Poster Abstracts Type: Oral Session: 615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: New Approaches to Combination Chemotherapy and Venetoclax Plus Hypomethylating Agent Therapy in AML Hematology Disease Topics & Pathways: adult, Clinical Practice (Health Services and Quality), Combination therapy, Therapies, therapy sequence, Study Population, Human Christoph R\u00f6llig, MD, MSC 1 *, Bj\u00f6rn Steffen, MD 2 *, Christoph", "unwound_url": "https://ash.confex.com/ash/2022/webprogram/Paper157126.html"}, {"start": 280, "end": 303, "url": "https://t.co/jeBqaap1mG", "expanded_url": "https://twitter.com/AaronGoodman33/status/1600519646028869633/photo/1", "display_url": "pic.twitter.com/jeBqaap1mG", "media_key": "3_1600519187624927232"}, {"start": 304, "end": 327, "url": "https://t.co/FLIlPqnyjy", "expanded_url": "https://twitter.com/AaronGoodman33/status/1600261398268764160", "display_url": "twitter.com/AaronGoodman33\u2026"}], "annotations": [{"start": 1, "end": 5, "probability": 0.5809, "type": "Other", "normalized_text": "ASH22"}, {"start": 48, "end": 55, "probability": 0.7452, "type": "Other", "normalized_text": "leukemia"}, {"start": 100, "end": 102, "probability": 0.385, "type": "Other", "normalized_text": "AML"}, {"start": 128, "end": 139, "probability": 0.6058, "type": "Other", "normalized_text": "daunorubicin"}, {"start": 225, "end": 236, "probability": 0.7264, "type": "Other", "normalized_text": "Daunorubicin"}], "hashtags": [{"start": 0, "end": 6, "tag": "ASH22"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "quoted", "id": "1600261398268764160"}], "edit_history_tweet_ids": ["1600519646028869633"], "created_at": "2022-12-07T15:56:34.000Z", "conversation_id": "1600519646028869633", "text": "#ASH22 Practice Changers\n\nAmazing study by team leukemia!\n\n2 questions in 1 trial!\n\nNewly diagnosed AML fit patients\n\nInduction daunorubicin 90 mg/m2 = 60 mg/m2!\n\nA 2nd induction with anthracycline not needed in responders.\n\nDaunorubicin dose = 60 mg/m2!\n\nhttps://t.co/pQ1sZbIV0g https://t.co/jeBqaap1mG https://t.co/FLIlPqnyjy", "lang": "en", "id": "1600519646028869633"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600478408659517440"}], "edit_history_tweet_ids": ["1600515070924316675"], "created_at": "2022-12-07T15:38:23.000Z", "conversation_id": "1600478408659517440", "entities": {"annotations": [{"start": 46, "end": 55, "probability": 0.8072, "type": "Other", "normalized_text": "isatuximab"}], "mentions": [{"start": 0, "end": 9, "username": "ManniMD1", "id": "1269642863924609025"}]}, "in_reply_to_user_id": "1269642863924609025", "text": "@ManniMD1 well that's because they didn't use isatuximab", "lang": "en", "id": "1600515070924316675"}, {"entities": {"urls": [{"start": 216, "end": 239, "url": "https://t.co/MzdOs6IcYM", "expanded_url": "https://twitter.com/AaronGoodman33/status/1600512579306016768/photo/1", "display_url": "pic.twitter.com/MzdOs6IcYM", "media_key": "3_1600512549727793152"}], "annotations": [{"start": 1, "end": 5, "probability": 0.5727, "type": "Other", "normalized_text": "ASH22"}, {"start": 57, "end": 64, "probability": 0.6676, "type": "Other", "normalized_text": "ASH 2022"}], "hashtags": [{"start": 0, "end": 6, "tag": "ASH22"}]}, "author_id": "854692626015993857", "edit_history_tweet_ids": ["1600512579306016768"], "created_at": "2022-12-07T15:28:29.000Z", "conversation_id": "1600512579306016768", "text": "#ASH22 \n\nIs anyone as eager as me for the release of the ASH 2022 Education Book!?\n\nHopefully they bring back the print edition as I always enjoyed reading it on my trip home and then cover to cover when I got home. https://t.co/MzdOs6IcYM", "lang": "en", "id": "1600512579306016768"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600467379158294528"}], "edit_history_tweet_ids": ["1600509053347966977"], "created_at": "2022-12-07T15:14:28.000Z", "conversation_id": "1600467379158294528", "in_reply_to_user_id": "2212735524", "entities": {"mentions": [{"start": 0, "end": 12, "username": "chadinabhan", "id": "2212735524"}, {"start": 13, "end": 27, "username": "BloodAdvances", "id": "732570175162179585"}, {"start": 28, "end": 38, "username": "ASkarbnik", "id": "999010996034338818"}, {"start": 39, "end": 51, "username": "GuiperiniMD", "id": "1294745239656202240"}, {"start": 61, "end": 71, "username": "ASkarbnik", "id": "999010996034338818"}]}, "text": "@chadinabhan @BloodAdvances @ASkarbnik @GuiperiniMD Whatever @ASkarbnik says I\u2019ll do the opposite.", "lang": "en", "id": "1600509053347966977"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1600283901821583360"}], "edit_history_tweet_ids": ["1600327580909211648"], "created_at": "2022-12-07T03:13:22.000Z", "conversation_id": "1600327580909211648", "entities": {"annotations": [{"start": 135, "end": 137, "probability": 0.8599, "type": "Organization", "normalized_text": "ANC"}], "mentions": [{"start": 3, "end": 15, "username": "marklewismd", "id": "807337182"}]}, "text": "RT @marklewismd: Of the many miseries endured by patients  in the hospital one of them is the needlessly restrictive diet \ud83d\udc47\ud83c\udffb p.o. &gt; ANC", "lang": "en", "id": "1600327580909211648"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600321063426326528"}], "edit_history_tweet_ids": ["1600321311385219072"], "created_at": "2022-12-07T02:48:27.000Z", "conversation_id": "1600320621426397184", "entities": {"annotations": [{"start": 38, "end": 44, "probability": 0.763, "type": "Other", "normalized_text": "myeloma"}, {"start": 76, "end": 83, "probability": 0.392, "type": "Other", "normalized_text": "leukemia"}], "mentions": [{"start": 0, "end": 9, "username": "ManniMD1", "id": "1269642863924609025"}]}, "in_reply_to_user_id": "854692626015993857", "text": "@ManniMD1 Not that I do much allo for myeloma. I do for primary plasma cell leukemia in young patient who understands the risks.", "lang": "en", "id": "1600321311385219072"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600320621426397184"}], "edit_history_tweet_ids": ["1600321063426326528"], "created_at": "2022-12-07T02:47:28.000Z", "conversation_id": "1600320621426397184", "in_reply_to_user_id": "1269642863924609025", "entities": {"mentions": [{"start": 0, "end": 9, "username": "ManniMD1", "id": "1269642863924609025"}]}, "text": "@ManniMD1 But perhaps the only true cure?", "lang": "en", "id": "1600321063426326528"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600320182240522240"}], "edit_history_tweet_ids": ["1600320539385507840"], "created_at": "2022-12-07T02:45:23.000Z", "conversation_id": "1600313165601857539", "in_reply_to_user_id": "854692626015993857", "entities": {"mentions": [{"start": 0, "end": 9, "username": "acweyand", "id": "824315782947631104"}, {"start": 10, "end": 22, "username": "AleckAmalia", "id": "1331336294828437504"}]}, "text": "@acweyand @AleckAmalia I can\u2019t spell.  \u201cThere\u201d", "lang": "en", "id": "1600320539385507840"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600313165601857539"}], "edit_history_tweet_ids": ["1600320182240522240"], "created_at": "2022-12-07T02:43:58.000Z", "conversation_id": "1600313165601857539", "entities": {"annotations": [{"start": 27, "end": 39, "probability": 0.877, "type": "Other", "normalized_text": "Cafe Du Monde"}], "mentions": [{"start": 0, "end": 9, "username": "acweyand", "id": "824315782947631104"}, {"start": 14, "end": 26, "username": "AleckAmalia", "id": "1331336294828437504"}]}, "in_reply_to_user_id": "824315782947631104", "text": "@acweyand Per @AleckAmalia Cafe Du Monde.  I will be going their daily.", "lang": "en", "id": "1600320182240522240"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600297330946678784"}], "edit_history_tweet_ids": ["1600297470130806787"], "created_at": "2022-12-07T01:13:43.000Z", "conversation_id": "1600254596235960320", "in_reply_to_user_id": "18821994", "entities": {"mentions": [{"start": 0, "end": 11, "username": "dgermain21", "id": "18821994"}, {"start": 12, "end": 28, "username": "PapaemmanuilLab", "id": "3154223927"}, {"start": 29, "end": 35, "username": "ash22", "id": "18618457"}]}, "text": "@dgermain21 @PapaemmanuilLab @ash22 Look forward to meeting you in person my friend!", "lang": "en", "id": "1600297470130806787"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600296085209202688"}], "edit_history_tweet_ids": ["1600297236516130816"], "created_at": "2022-12-07T01:12:47.000Z", "conversation_id": "1600296085209202688", "in_reply_to_user_id": "1026947037080772610", "entities": {"mentions": [{"start": 0, "end": 13, "username": "Abdallah81MD", "id": "1026947037080772610"}]}, "text": "@Abdallah81MD Solid plan", "lang": "en", "id": "1600297236516130816"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600254596235960320"}], "edit_history_tweet_ids": ["1600296136417619968"], "created_at": "2022-12-07T01:08:25.000Z", "conversation_id": "1600254596235960320", "in_reply_to_user_id": "3154223927", "entities": {"mentions": [{"start": 0, "end": 16, "username": "PapaemmanuilLab", "id": "3154223927"}, {"start": 17, "end": 23, "username": "ash22", "id": "18618457"}]}, "text": "@PapaemmanuilLab @ash22 I\u2019ll be there!", "lang": "en", "id": "1600296136417619968"}, {"entities": {"urls": [{"start": 261, "end": 284, "url": "https://t.co/sKNJ3DN7sU", "expanded_url": "https://twitter.com/AaronGoodman33/status/1600261398268764160/photo/1", "display_url": "pic.twitter.com/sKNJ3DN7sU", "media_key": "3_1600260629113077760"}, {"start": 285, "end": 308, "url": "https://t.co/ewKqTmAQ1u", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599925397139099648", "display_url": "twitter.com/AaronGoodman33\u2026"}], "annotations": [{"start": 1, "end": 5, "probability": 0.6249, "type": "Other", "normalized_text": "ASH22"}, {"start": 151, "end": 154, "probability": 0.7166, "type": "Other", "normalized_text": "HSCT"}], "hashtags": [{"start": 0, "end": 6, "tag": "ASH22"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "quoted", "id": "1599925397139099648"}], "edit_history_tweet_ids": ["1600261398268764160"], "created_at": "2022-12-06T22:50:23.000Z", "conversation_id": "1600261398268764160", "text": "#ASH22 Practice Changers\n\nTime to abolish for good the neutropenic diet!\nLet patients with cancer eat what ever they want even if neutropenic.\n\nRCT in HSCT or induction chemo pts\nRandomized 1:1 to standard diet or protective diet.\n\nNo difference in infections! https://t.co/sKNJ3DN7sU https://t.co/ewKqTmAQ1u", "lang": "en", "id": "1600261398268764160"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600202096393224193"}], "edit_history_tweet_ids": ["1600245303760023552"], "created_at": "2022-12-06T21:46:26.000Z", "conversation_id": "1599065279786409985", "entities": {"annotations": [{"start": 77, "end": 83, "probability": 0.9859, "type": "Organization", "normalized_text": "Beatles"}, {"start": 123, "end": 133, "probability": 0.6495, "type": "Other", "normalized_text": "White album"}, {"start": 138, "end": 145, "probability": 0.714, "type": "Other", "normalized_text": "Revolver"}, {"start": 150, "end": 160, "probability": 0.6923, "type": "Other", "normalized_text": "Sgt Peppers"}, {"start": 165, "end": 174, "probability": 0.8863, "type": "Other", "normalized_text": "Abbey Road"}, {"start": 179, "end": 189, "probability": 0.8885, "type": "Other", "normalized_text": "Rubber soul"}, {"start": 194, "end": 213, "probability": 0.9177, "type": "Other", "normalized_text": "Magical mystery tour"}, {"start": 218, "end": 226, "probability": 0.9697, "type": "Other", "normalized_text": "Let it Be"}, {"start": 231, "end": 246, "probability": 0.7139, "type": "Organization", "normalized_text": "Beatles for sale"}, {"start": 251, "end": 258, "probability": 0.518, "type": "Other", "normalized_text": "With the"}, {"start": 260, "end": 266, "probability": 0.7233, "type": "Organization", "normalized_text": "Beatles"}], "mentions": [{"start": 0, "end": 10, "username": "ASkarbnik", "id": "999010996034338818"}, {"start": 11, "end": 23, "username": "matthew_mei", "id": "354168091"}, {"start": 24, "end": 36, "username": "GuiperiniMD", "id": "1294745239656202240"}, {"start": 37, "end": 50, "username": "paulocruzphi", "id": "1913011345"}]}, "in_reply_to_user_id": "999010996034338818", "text": "@ASkarbnik @matthew_mei @GuiperiniMD @paulocruzphi If we are discussing best Beatles albums the order is as following \n\n1. White album\n2. Revolver\n3. Sgt Peppers\n4. Abbey Road\n5. Rubber soul\n6. Magical mystery tour\n7. Let it Be\n8. Beatles for sale\n9. With the Beatles", "lang": "en", "id": "1600245303760023552"}, {"entities": {"urls": [{"start": 115, "end": 138, "url": "https://t.co/kfx3VK1WJs", "expanded_url": "https://pubmed.ncbi.nlm.nih.gov/34652953/", "display_url": "pubmed.ncbi.nlm.nih.gov/34652953/", "images": [{"url": "https://pbs.twimg.com/news_img/1600165251340652550/EMGpTkfM?format=jpg&name=orig", "width": 1200, "height": 1200}, {"url": "https://pbs.twimg.com/news_img/1600165251340652550/EMGpTkfM?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Perils of Ignoring Overall Survival in Interpreting the Myeloma Literature - PubMed", "description": "Perils of Ignoring Overall Survival in Interpreting the Myeloma Literature", "unwound_url": "https://pubmed.ncbi.nlm.nih.gov/34652953/"}], "annotations": [{"start": 56, "end": 73, "probability": 0.7236, "type": "Other", "normalized_text": "Myeloma Literature"}], "mentions": [{"start": 86, "end": 95, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 99, "end": 112, "username": "drkevinknopf", "id": "1084451400"}]}, "author_id": "854692626015993857", "edit_history_tweet_ids": ["1600165250346541056"], "created_at": "2022-12-06T16:28:19.000Z", "conversation_id": "1600165250346541056", "text": "Perils of Ignoring Overall Survival in Interpreting the Myeloma Literature - PubMed\n\n\u2066@ManniMD1\u2069 \n\u2066@drkevinknopf\u2069  https://t.co/kfx3VK1WJs", "lang": "en", "id": "1600165250346541056"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599947443327893504"}], "edit_history_tweet_ids": ["1599950096439054336"], "created_at": "2022-12-06T02:13:23.000Z", "conversation_id": "1599925397139099648", "in_reply_to_user_id": "354168091", "entities": {"mentions": [{"start": 0, "end": 12, "username": "matthew_mei", "id": "354168091"}, {"start": 13, "end": 23, "username": "ASkarbnik", "id": "999010996034338818"}, {"start": 24, "end": 36, "username": "GuiperiniMD", "id": "1294745239656202240"}]}, "text": "@matthew_mei @ASkarbnik @GuiperiniMD I\u2019ll be there Thursday through Monday.  Text me when you get in", "lang": "en", "id": "1599950096439054336"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599942610046824449"}], "edit_history_tweet_ids": ["1599943208800497664"], "created_at": "2022-12-06T01:46:01.000Z", "conversation_id": "1599925397139099648", "entities": {"annotations": [{"start": 37, "end": 44, "probability": 0.4808, "type": "Other", "normalized_text": "Triangle"}, {"start": 221, "end": 227, "probability": 0.6526, "type": "Other", "normalized_text": "myeloma"}], "mentions": [{"start": 0, "end": 12, "username": "matthew_mei", "id": "354168091"}, {"start": 13, "end": 25, "username": "GuiperiniMD", "id": "1294745239656202240"}, {"start": 26, "end": 36, "username": "ASkarbnik", "id": "999010996034338818"}]}, "in_reply_to_user_id": "854692626015993857", "text": "@matthew_mei @GuiperiniMD @ASkarbnik Triangle you take a pill and you might not need auto and expect similar remission.   SHINE you take a pill and delay time to taking pill without removing other therapy.  3 vs 2 like a myeloma trial.", "lang": "en", "id": "1599943208800497664"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599941573659463680"}], "edit_history_tweet_ids": ["1599942610046824449"], "created_at": "2022-12-06T01:43:38.000Z", "conversation_id": "1599925397139099648", "entities": {"annotations": [{"start": 258, "end": 262, "probability": 0.7584, "type": "Other", "normalized_text": "SHINE"}], "mentions": [{"start": 0, "end": 12, "username": "matthew_mei", "id": "354168091"}, {"start": 13, "end": 25, "username": "GuiperiniMD", "id": "1294745239656202240"}, {"start": 26, "end": 36, "username": "ASkarbnik", "id": "999010996034338818"}]}, "in_reply_to_user_id": "354168091", "text": "@matthew_mei @GuiperiniMD @ASkarbnik This study gets rid of one toxic therapy (auto) and replaces with something else.  SHINE just adds therapy we know works.\n\nNeither are truly practice changing if you read my attached tweet although this study better than SHINE which just confirmed the obvious.", "lang": "en", "id": "1599942610046824449"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599930810962182144"}], "edit_history_tweet_ids": ["1599933239589998592"], "created_at": "2022-12-06T01:06:24.000Z", "conversation_id": "1599925397139099648", "entities": {"annotations": [{"start": 28, "end": 36, "probability": 0.8487, "type": "Other", "normalized_text": "HyperCVAD"}, {"start": 42, "end": 52, "probability": 0.6262, "type": "Other", "normalized_text": "MCL\n\nLAtely"}, {"start": 92, "end": 98, "probability": 0.7376, "type": "Other", "normalized_text": "R-HiDAC"}], "mentions": [{"start": 0, "end": 14, "username": "davideyoungmd", "id": "2170420038"}]}, "in_reply_to_user_id": "2170420038", "text": "@davideyoungmd I do not use HyperCVAD for MCL\n\nLAtely I have been using BR alternating with R-HiDAC or just BR on its own", "lang": "en", "id": "1599933239589998592"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599929906628284416"}], "edit_history_tweet_ids": ["1599930678090792960"], "created_at": "2022-12-06T00:56:13.000Z", "conversation_id": "1599925397139099648", "entities": {"annotations": [{"start": 29, "end": 43, "probability": 0.6669, "type": "Other", "normalized_text": "SHINE ibrutinib"}, {"start": 82, "end": 90, "probability": 0.7194, "type": "Other", "normalized_text": "ibrutinib"}], "mentions": [{"start": 0, "end": 12, "username": "matthew_mei", "id": "354168091"}]}, "in_reply_to_user_id": "354168091", "text": "@matthew_mei Did you know in SHINE ibrutinib maintenance delayed time to starting ibrutinib.", "lang": "en", "id": "1599930678090792960"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1598728138812710912"}], "edit_history_tweet_ids": ["1599927311125843968"], "created_at": "2022-12-06T00:42:50.000Z", "conversation_id": "1599927311125843968", "entities": {"annotations": [{"start": 58, "end": 62, "probability": 0.6569, "type": "Other", "normalized_text": "ASH22"}, {"start": 111, "end": 116, "probability": 0.7636, "type": "Other", "normalized_text": "BMTCTN"}], "mentions": [{"start": 3, "end": 18, "username": "AaronGoodman33", "id": "854692626015993857"}], "hashtags": [{"start": 57, "end": 63, "tag": "ASH22"}]}, "text": "RT @AaronGoodman33: I will be sharing over next few days #ASH22 abstracts that are practice changing for me! \n\nBMTCTN 1703 by legendary bas\u2026", "lang": "en", "id": "1599927311125843968"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1599093726345056256"}], "edit_history_tweet_ids": ["1599927267500912640"], "created_at": "2022-12-06T00:42:40.000Z", "conversation_id": "1599927267500912640", "entities": {"mentions": [{"start": 3, "end": 18, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 52, "end": 66, "username": "MartinTallman", "id": "1334487799718961153"}], "hashtags": [{"start": 20, "end": 26, "tag": "ASH22"}]}, "text": "RT @AaronGoodman33: #ASH22 Practice Changers\n\nE1910 @MartinTallman\n\nPh- B-ALL (30-70 yo) \nBFM-like induction [PEG if&lt;55 yo,ritux if CD20+]\u2026", "lang": "en", "id": "1599927267500912640"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1599779550753193985"}], "edit_history_tweet_ids": ["1599926967360720897"], "created_at": "2022-12-06T00:41:28.000Z", "conversation_id": "1599926967360720897", "entities": {"annotations": [{"start": 15, "end": 19, "probability": 0.6877, "type": "Other", "normalized_text": "ASH22"}, {"start": 131, "end": 137, "probability": 0.7355, "type": "Other", "normalized_text": "myeloma"}], "mentions": [{"start": 3, "end": 12, "username": "ManniMD1", "id": "1269642863924609025"}], "hashtags": [{"start": 14, "end": 20, "tag": "ASH22"}]}, "text": "RT @ManniMD1: #ASH22 starts this week.\n\nHere is a list of top 10 abstracts that have already influenced my thought and practice in myeloma!\u2026", "lang": "en", "id": "1599926967360720897"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599925397139099648"}], "edit_history_tweet_ids": ["1599926111143866368"], "created_at": "2022-12-06T00:38:04.000Z", "conversation_id": "1599925397139099648", "entities": {"annotations": [{"start": 49, "end": 57, "probability": 0.5657, "type": "Other", "normalized_text": "ibrutinib"}, {"start": 158, "end": 160, "probability": 0.3926, "type": "Organization", "normalized_text": "FFS"}, {"start": 185, "end": 186, "probability": 0.5433, "type": "Other", "normalized_text": "OS"}, {"start": 223, "end": 226, "probability": 0.5962, "type": "Other", "normalized_text": "ASCT"}]}, "in_reply_to_user_id": "854692626015993857", "text": "I do not know if this will change my practice as ibrutinib maintenance is no walk in park, but will have long discussion with patient about approaches.\n\nAlso FFS not best endpoint, and OS all the same, but its good to know ASCT can be omitted.", "lang": "en", "id": "1599926111143866368"}, {"entities": {"urls": [{"start": 290, "end": 313, "url": "https://t.co/btoPwYi8KK", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599925397139099648/photo/1", "display_url": "pic.twitter.com/btoPwYi8KK", "media_key": "3_1599925066690502656"}, {"start": 314, "end": 337, "url": "https://t.co/pG7exZwa7f", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599093726345056256", "display_url": "twitter.com/AaronGoodman33\u2026"}], "annotations": [{"start": 53, "end": 63, "probability": 0.5267, "type": "Other", "normalized_text": "Mantle Cell"}, {"start": 94, "end": 98, "probability": 0.5004, "type": "Other", "normalized_text": "RCHOP"}, {"start": 100, "end": 103, "probability": 0.5465, "type": "Other", "normalized_text": "DHAP"}, {"start": 107, "end": 115, "probability": 0.5074, "type": "Other", "normalized_text": "ibrutinib"}, {"start": 129, "end": 133, "probability": 0.505, "type": "Other", "normalized_text": "RCHOP"}, {"start": 135, "end": 138, "probability": 0.4628, "type": "Other", "normalized_text": "DHAP"}, {"start": 165, "end": 169, "probability": 0.481, "type": "Other", "normalized_text": "RCHOP"}, {"start": 171, "end": 174, "probability": 0.508, "type": "Other", "normalized_text": "DHAP"}, {"start": 275, "end": 283, "probability": 0.5558, "type": "Other", "normalized_text": "ibrutinib"}], "hashtags": [{"start": 0, "end": 6, "tag": "ASH22"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "quoted", "id": "1599093726345056256"}], "edit_history_tweet_ids": ["1599925397139099648"], "created_at": "2022-12-06T00:35:14.000Z", "conversation_id": "1599925397139099648", "text": "#ASH22 Practice Changers\n\nTriangle study!\n\nFrontline Mantle Cell\nTransplant eligible\n\n3 arms*\nRCHOP/DHAP + ibrutinib-&gt;I maint\nRCHOP/DHAP + I-&gt;ASCT-&gt;I maint\nRCHOP/DHAP-&gt;ASCT\n*ritux maint allowed\n\nFFS equal in ibrutinib arms regardless of ASCT or not\n\nCan \ud83d\udeabASCT if ibrutinib used https://t.co/btoPwYi8KK https://t.co/pG7exZwa7f", "lang": "en", "id": "1599925397139099648"}, {"author_id": "854692626015993857", "edit_history_tweet_ids": ["1599904633711136769"], "created_at": "2022-12-05T23:12:44.000Z", "conversation_id": "1599904633711136769", "entities": {"annotations": [{"start": 14, "end": 20, "probability": 0.7568, "type": "Other", "normalized_text": "myeloma"}]}, "text": "My smoldering myeloma treatment guidelines!", "lang": "en", "id": "1599904633711136769"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599872039862824960"}], "edit_history_tweet_ids": ["1599880052531154944"], "created_at": "2022-12-05T21:35:03.000Z", "conversation_id": "1599859955275735040", "entities": {"annotations": [{"start": 42, "end": 46, "probability": 0.6748, "type": "Other", "normalized_text": "ASH22"}], "mentions": [{"start": 0, "end": 13, "username": "VPrasadMDMPH", "id": "1194962714"}], "hashtags": [{"start": 41, "end": 47, "tag": "ASH22"}]}, "in_reply_to_user_id": "1194962714", "text": "@VPrasadMDMPH Are you the discuss any at #ASH22 this year?  Would be interesting and educational.", "lang": "en", "id": "1599880052531154944"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599859955275735040"}], "edit_history_tweet_ids": ["1599868146663690240"], "created_at": "2022-12-05T20:47:44.000Z", "conversation_id": "1599859955275735040", "entities": {"annotations": [{"start": 56, "end": 59, "probability": 0.783, "type": "Other", "normalized_text": "IMWG"}], "mentions": [{"start": 0, "end": 13, "username": "VPrasadMDMPH", "id": "1194962714"}]}, "in_reply_to_user_id": "1194962714", "text": "@VPrasadMDMPH awesome, maybe you will be invited to the IMWG next?  I hope so.  I think in person people will realize we are all on the same team (how to best help our patients) we just have different approaches, we can all learn from each other", "lang": "en", "id": "1599868146663690240"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599826784786477057"}], "edit_history_tweet_ids": ["1599829917805711360"], "created_at": "2022-12-05T18:15:50.000Z", "conversation_id": "1599826784786477057", "in_reply_to_user_id": "1269642863924609025", "entities": {"mentions": [{"start": 0, "end": 9, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 10, "end": 16, "username": "Optum", "id": "318007077"}]}, "text": "@ManniMD1 @Optum Yea DM is just so they look like they care for all of a second", "lang": "en", "id": "1599829917805711360"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1599787532568252422"}], "edit_history_tweet_ids": ["1599788024380162048"], "created_at": "2022-12-05T15:29:22.000Z", "conversation_id": "1599788024380162048", "entities": {"annotations": [{"start": 76, "end": 81, "probability": 0.9717, "type": "Place", "normalized_text": "Boston"}], "mentions": [{"start": 3, "end": 14, "username": "Jmarksloan", "id": "1578929666"}]}, "text": "RT @Jmarksloan: Looking for an A+  hematology clinician investigator job in Boston?  We would love to hear from you. Graduating fellows wel\u2026", "lang": "en", "id": "1599788024380162048"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599578871611158530"}], "edit_history_tweet_ids": ["1599580615590154241"], "created_at": "2022-12-05T01:45:12.000Z", "conversation_id": "1599557478538043394", "in_reply_to_user_id": "1126106500701806592", "entities": {"mentions": [{"start": 0, "end": 14, "username": "DeleeuwHalley", "id": "1126106500701806592"}]}, "text": "@DeleeuwHalley So far so good", "lang": "en", "id": "1599580615590154241"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599560167322181632"}], "edit_history_tweet_ids": ["1599561683084922880"], "created_at": "2022-12-05T00:29:58.000Z", "conversation_id": "1599557478538043394", "entities": {"annotations": [{"start": 84, "end": 92, "probability": 0.9374, "type": "Other", "normalized_text": "Malignant"}], "mentions": [{"start": 0, "end": 13, "username": "VPrasadMDMPH", "id": "1194962714"}]}, "in_reply_to_user_id": "1194962714", "text": "@VPrasadMDMPH Yes this is my first book recommendation from you other than to read \u201cMalignant\u201d but that doesn\u2019t count.", "lang": "en", "id": "1599561683084922880"}, {"entities": {"urls": [{"start": 22, "end": 45, "url": "https://t.co/4jYeJbKTAe", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599557478538043394/photo/1", "display_url": "pic.twitter.com/4jYeJbKTAe", "media_key": "3_1599557463140802560"}]}, "author_id": "854692626015993857", "edit_history_tweet_ids": ["1599557478538043394"], "created_at": "2022-12-05T00:13:15.000Z", "conversation_id": "1599557478538043394", "text": "Excited to read this! https://t.co/4jYeJbKTAe", "lang": "en", "id": "1599557478538043394"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1599445097224892418"}], "edit_history_tweet_ids": ["1599445953060417537"], "created_at": "2022-12-04T16:50:06.000Z", "conversation_id": "1599445953060417537", "entities": {"mentions": [{"start": 3, "end": 12, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 110, "end": 122, "username": "TargetedOnc", "id": "726304448"}]}, "text": "RT @ManniMD1: Is it fair for us to politely ask (without disrespecting the people being interviewed) who pays @TargetedOnc for this content\u2026", "lang": "en", "id": "1599445953060417537"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599440890803630081"}], "edit_history_tweet_ids": ["1599443737704206336"], "created_at": "2022-12-04T16:41:17.000Z", "conversation_id": "1599440890803630081", "in_reply_to_user_id": "1144997352148787201", "entities": {"mentions": [{"start": 0, "end": 14, "username": "Dr_AmerZeidan", "id": "1144997352148787201"}]}, "text": "@Dr_AmerZeidan if you read his tweets he does not agree with the statement, this was just a question", "lang": "en", "id": "1599443737704206336"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599416272323690496"}], "edit_history_tweet_ids": ["1599425936197586944"], "created_at": "2022-12-04T15:30:33.000Z", "conversation_id": "1599057168103538690", "in_reply_to_user_id": "913851074", "entities": {"mentions": [{"start": 0, "end": 9, "username": "CoachBon", "id": "913851074"}, {"start": 10, "end": 19, "username": "ManniMD1", "id": "1269642863924609025"}]}, "text": "@CoachBon @ManniMD1 No one would unless they are poorly consented for this trial.   The trial should be closed or at the very least amended to exclude intermediate risk.", "lang": "en", "id": "1599425936197586944"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1599219692559745024"}], "edit_history_tweet_ids": ["1599220929099628544"], "created_at": "2022-12-04T01:55:56.000Z", "conversation_id": "1599220929099628544", "entities": {"annotations": [{"start": 26, "end": 41, "probability": 0.3423, "type": "Other", "normalized_text": "Chicago Leukemia"}, {"start": 43, "end": 49, "probability": 0.5948, "type": "Other", "normalized_text": "myeloid"}, {"start": 59, "end": 65, "probability": 0.9054, "type": "Other", "normalized_text": "Twitter"}], "mentions": [{"start": 3, "end": 18, "username": "Anand_88_Patel", "id": "2417458314"}, {"start": 114, "end": 127, "username": "UChicagoLeuk", "id": "1599205265928224768"}]}, "text": "RT @Anand_88_Patel: The U Chicago Leukemia/myeloid program Twitter account is up and running! Give it a follow at @UChicagoLeuk\n\n@myeloidma\u2026", "lang": "en", "id": "1599220929099628544"}, {"entities": {"urls": [{"start": 72, "end": 95, "url": "https://t.co/XErs9CqUKs", "expanded_url": "https://twitter.com/VPrasadMDMPH/status/1599210886518173697", "display_url": "twitter.com/VPrasadMDMPH/s\u2026"}], "annotations": [{"start": 55, "end": 61, "probability": 0.6104, "type": "Other", "normalized_text": "myeloma"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "quoted", "id": "1599210886518173697"}], "edit_history_tweet_ids": ["1599211552401674240"], "created_at": "2022-12-04T01:18:40.000Z", "conversation_id": "1599211552401674240", "text": "I didn\u2019t even think 20,000 people knew what smoldering myeloma even is. https://t.co/XErs9CqUKs", "lang": "en", "id": "1599211552401674240"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599207509738209280"}], "edit_history_tweet_ids": ["1599207737229185029"], "created_at": "2022-12-04T01:03:31.000Z", "conversation_id": "1599142217792516096", "in_reply_to_user_id": "18792477", "entities": {"mentions": [{"start": 0, "end": 9, "username": "geekbabe", "id": "18792477"}, {"start": 10, "end": 23, "username": "BrownHospMed", "id": "1493597471074832393"}]}, "text": "@geekbabe @BrownHospMed All natural", "lang": "en", "id": "1599207737229185029"}, {"entities": {"urls": [{"start": 217, "end": 240, "url": "https://t.co/ls6afOA0Yx", "expanded_url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2768843", "display_url": "jamanetwork.com/journals/jaman\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1599223661332140032/7VAoLwZX?format=jpg&name=orig", "width": 1600, "height": 840}, {"url": "https://pbs.twimg.com/news_img/1599223661332140032/7VAoLwZX?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Are Observational, Real-World Studies Suitable to Make Cancer Treatment Recommendations?", "description": "Kumar et al1 added a new chapter to a decades-long debate about whether observational studies\u2014nonrandomized comparative effectiveness research (CER)\u2014can replace randomized clinical trials (RCTs) to assess the efficacy of therapies. Their work is timely. The 21st Century Cures Act has empowered the...", "unwound_url": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2768843"}], "annotations": [{"start": 165, "end": 172, "probability": 0.45, "type": "Other", "normalized_text": "ions? | "}, {"start": 176, "end": 192, "probability": 0.5921, "type": "Other", "normalized_text": "ology | JAMA Netw"}, {"start": 196, "end": 207, "probability": 0.6099, "type": "Other", "normalized_text": " Open | JAMA"}], "mentions": [{"start": 42, "end": 58, "username": "RahulBanerjeeMD", "id": "26399236"}, {"start": 65, "end": 78, "username": "VPrasadMDMPH", "id": "1194962714"}]}, "author_id": "854692626015993857", "edit_history_tweet_ids": ["1599201271558287360"], "created_at": "2022-12-04T00:37:49.000Z", "conversation_id": "1599201271558287360", "text": "An interesting commentary I just read by \u2066@RahulBanerjeeMD\u2069 and \u2066@VPrasadMDMPH\u2069!\n\nAre Observational, Real-World Studies Suitable to Make Cancer Treatment Recommendations? | Oncology | JAMA Network Open | JAMA Network https://t.co/ls6afOA0Yx", "lang": "en", "id": "1599201271558287360"}, {"entities": {"urls": [{"start": 208, "end": 231, "url": "https://t.co/gala98hYjA", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599194264122306560/photo/1", "display_url": "pic.twitter.com/gala98hYjA", "media_key": "3_1599194254340808705"}], "annotations": [{"start": 54, "end": 56, "probability": 0.4059, "type": "Other", "normalized_text": "WHO"}, {"start": 75, "end": 90, "probability": 0.484, "type": "Other", "normalized_text": "leukemia variant"}, {"start": 134, "end": 140, "probability": 0.5508, "type": "Other", "normalized_text": "splenic"}, {"start": 144, "end": 147, "probability": 0.4682, "type": "Other", "normalized_text": "cell"}, {"start": 158, "end": 165, "probability": 0.6418, "type": "Other", "normalized_text": "leukemia"}], "mentions": [{"start": 0, "end": 16, "username": "LeonidasPlatan1", "id": "1117857169528033280"}, {"start": 17, "end": 30, "username": "BrownHospMed", "id": "1493597471074832393"}, {"start": 194, "end": 207, "username": "sanamloghavi", "id": "3076847052"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599193443711930369"}], "edit_history_tweet_ids": ["1599194264122306560"], "created_at": "2022-12-04T00:09:58.000Z", "conversation_id": "1599142217792516096", "in_reply_to_user_id": "1117857169528033280", "text": "@LeonidasPlatan1 @BrownHospMed A teaching point.  Per WHO 2022 \"hairy cell leukemia variant\" no longer exists.  \n\nIt is now known as \"splenic B-cell lymphoma/leukemia with prominent nucleoli\"!\n\n@sanamloghavi https://t.co/gala98hYjA", "lang": "en", "id": "1599194264122306560"}, {"entities": {"urls": [{"start": 14, "end": 37, "url": "https://t.co/8MYLg8olPs", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599192787391778820/photo/1", "display_url": "pic.twitter.com/8MYLg8olPs", "media_key": "3_1599192781229989888"}], "mentions": [{"start": 0, "end": 13, "username": "BrownHospMed", "id": "1493597471074832393"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599142217792516096"}], "edit_history_tweet_ids": ["1599192787391778820"], "created_at": "2022-12-04T00:04:06.000Z", "conversation_id": "1599142217792516096", "in_reply_to_user_id": "1493597471074832393", "text": "@BrownHospMed https://t.co/8MYLg8olPs", "lang": "qme", "id": "1599192787391778820"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1599137975329492992"}], "edit_history_tweet_ids": ["1599187885626126336"], "created_at": "2022-12-03T23:44:38.000Z", "conversation_id": "1599187885626126336", "entities": {"mentions": [{"start": 3, "end": 19, "username": "Plenary_Session", "id": "1028063001755103233"}, {"start": 43, "end": 59, "username": "Plenary_Session", "id": "1028063001755103233"}]}, "text": "RT @Plenary_Session: Now on the audio feed @Plenary_Session!", "lang": "en", "id": "1599187885626126336"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1599145203348082689"}], "edit_history_tweet_ids": ["1599187868223967232"], "created_at": "2022-12-03T23:44:33.000Z", "conversation_id": "1599187868223967232", "entities": {"annotations": [{"start": 31, "end": 37, "probability": 0.9761, "type": "Other", "normalized_text": "Twitter"}], "mentions": [{"start": 3, "end": 18, "username": "massimodigioia", "id": "461579451"}]}, "text": "RT @massimodigioia: Why I love Twitter\u2026", "lang": "en", "id": "1599187868223967232"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1599169972072169472"}], "edit_history_tweet_ids": ["1599175260347469824"], "created_at": "2022-12-03T22:54:27.000Z", "conversation_id": "1599175260347469824", "entities": {"annotations": [{"start": 50, "end": 54, "probability": 0.7104, "type": "Other", "normalized_text": "Vinay"}, {"start": 84, "end": 90, "probability": 0.9896, "type": "Other", "normalized_text": "Twitter"}], "mentions": [{"start": 3, "end": 15, "username": "Timothee_MD", "id": "1472332068914962433"}]}, "text": "RT @Timothee_MD: Wow! Great new video series from Vinay !\nI enjoyed it a lot !\n\nMed Twitter is alive, for sure !\nWell done \ud83d\udc4f", "lang": "en", "id": "1599175260347469824"}, {"entities": {"urls": [{"start": 107, "end": 130, "url": "https://t.co/ICdbVyNjej", "expanded_url": "https://twitter.com/Dr_RShatsky/status/1599082579202027521", "display_url": "twitter.com/Dr_RShatsky/st\u2026"}], "annotations": [{"start": 46, "end": 52, "probability": 0.9431, "type": "Place", "normalized_text": "America"}], "mentions": [{"start": 10, "end": 21, "username": "UCSDHealth", "id": "107258201"}, {"start": 22, "end": 33, "username": "UCSDCancer", "id": "1473383250995281922"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "quoted", "id": "1599082579202027521"}], "edit_history_tweet_ids": ["1599151777923768320"], "created_at": "2022-12-03T21:21:09.000Z", "conversation_id": "1599151777923768320", "text": "Come work @UCSDHealth @ucsdcancer and live in America\u2019s finest city while working with amazing colleagues. https://t.co/ICdbVyNjej", "lang": "en", "id": "1599151777923768320"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1599138243228073985"}], "edit_history_tweet_ids": ["1599150142997024768"], "created_at": "2022-12-03T21:14:39.000Z", "conversation_id": "1599150142997024768", "entities": {"mentions": [{"start": 3, "end": 19, "username": "Plenary_Session", "id": "1028063001755103233"}]}, "text": "RT @Plenary_Session: Plenary Session Downloads are Insane\nMillions of downloads &amp; growing\nMost Popular Heme Onc Podcast Globally\nThanks to\u2026", "lang": "en", "id": "1599150142997024768"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599126088411541504"}], "edit_history_tweet_ids": ["1599127168306491392"], "created_at": "2022-12-03T19:43:21.000Z", "conversation_id": "1599126088411541504", "entities": {"annotations": [{"start": 122, "end": 131, "probability": 0.6611, "type": "Other", "normalized_text": "medtwitter"}], "mentions": [{"start": 0, "end": 13, "username": "VPrasadMDMPH", "id": "1194962714"}, {"start": 14, "end": 30, "username": "Plenary_Session", "id": "1028063001755103233"}], "hashtags": [{"start": 121, "end": 132, "tag": "medtwitter"}]}, "in_reply_to_user_id": "1194962714", "text": "@VPrasadMDMPH @Plenary_Session It was more of a friendly debate than a battle.  It was some good old fashioned precovid  #medtwitter.", "lang": "en", "id": "1599127168306491392"}, {"entities": {"urls": [{"start": 28, "end": 51, "url": "https://t.co/qCmaJIpKGR", "expanded_url": "https://twitter.com/vprasadmdmph/status/1599126088411541504", "display_url": "twitter.com/vprasadmdmph/s\u2026"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "quoted", "id": "1599126088411541504"}], "edit_history_tweet_ids": ["1599126916430430208"], "created_at": "2022-12-03T19:42:21.000Z", "conversation_id": "1599126916430430208", "text": "This should be interesting. https://t.co/qCmaJIpKGR", "lang": "en", "id": "1599126916430430208"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599115678836924416"}], "edit_history_tweet_ids": ["1599123604607668224"], "created_at": "2022-12-03T19:29:12.000Z", "conversation_id": "1599115678836924416", "entities": {"annotations": [{"start": 107, "end": 109, "probability": 0.539, "type": "Organization", "normalized_text": "ASH"}], "mentions": [{"start": 0, "end": 8, "username": "GKaurMD", "id": "28731834"}]}, "in_reply_to_user_id": "28731834", "text": "@GKaurMD Thank you for your feedback.   Please see tweets describing wonderful practice changing trials at ASH.  Unfortunately none were myeloma trials this year. There is always next year.", "lang": "en", "id": "1599123604607668224"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599110786210676736"}], "edit_history_tweet_ids": ["1599121358063304704"], "created_at": "2022-12-03T19:20:16.000Z", "conversation_id": "1598826846082121728", "in_reply_to_user_id": "1294745239656202240", "entities": {"mentions": [{"start": 0, "end": 12, "username": "GuiperiniMD", "id": "1294745239656202240"}, {"start": 13, "end": 25, "username": "chadinabhan", "id": "2212735524"}, {"start": 55, "end": 65, "username": "ASkarbnik", "id": "999010996034338818"}]}, "text": "@GuiperiniMD @chadinabhan Maybe I\u2019ll bring my guitar.  @ASkarbnik will you have access to keyboard?", "lang": "en", "id": "1599121358063304704"}, {"entities": {"urls": [{"start": 129, "end": 152, "url": "https://t.co/dYRC5XHjkk", "expanded_url": "https://podcasts.apple.com/us/podcast/healthcare-unfiltered/id1534737585?i=1000504388176", "display_url": "podcasts.apple.com/us/podcast/hea\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1599120211851952129/g84ya1ma?format=jpg&name=orig", "width": 1200, "height": 600}, {"url": "https://pbs.twimg.com/news_img/1599120211851952129/g84ya1ma?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "\u200eHealthcare Unfiltered: Drug Approvals and Real-World Use: The Case of Selinexor in Multiple Myeloma on Apple Podcasts", "description": "\u200eShow Healthcare Unfiltered, Ep Drug Approvals and Real-World Use: The Case of Selinexor in Multiple Myeloma - Jan 5, 2021", "unwound_url": "https://podcasts.apple.com/us/podcast/healthcare-unfiltered/id1534737585?i=1000504388176"}], "annotations": [{"start": 58, "end": 67, "probability": 0.7215, "type": "Other", "normalized_text": " of Karyop"}, {"start": 84, "end": 92, "probability": 0.6141, "type": "Other", "normalized_text": " of selin"}], "mentions": [{"start": 22, "end": 34, "username": "chadinabhan", "id": "2212735524"}]}, "author_id": "854692626015993857", "edit_history_tweet_ids": ["1599120209306013697"], "created_at": "2022-12-03T19:15:42.000Z", "conversation_id": "1599120209306013697", "text": "Classic Podcast with \u2066@chadinabhan\u2069 where I debate the CMO of Karyopharm on the role of selinexor and the infamous BOSTON study. https://t.co/dYRC5XHjkk", "lang": "en", "id": "1599120209306013697"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1599106602958999552"}], "edit_history_tweet_ids": ["1599119141205868544"], "created_at": "2022-12-03T19:11:28.000Z", "conversation_id": "1599119141205868544", "entities": {"annotations": [{"start": 29, "end": 57, "probability": 0.8481, "type": "Other", "normalized_text": "Chronic Granulomatous Disease"}, {"start": 131, "end": 135, "probability": 0.5084, "type": "Other", "normalized_text": "NADPH"}], "mentions": [{"start": 3, "end": 11, "username": "Sthanu5", "id": "821765042051784705"}, {"start": 13, "end": 28, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "text": "RT @Sthanu5: @AaronGoodman33 Chronic Granulomatous Disease\n\ndefective function of the nicotinamide adenine dinucleotide phosphate (NADPH) o\u2026", "lang": "en", "id": "1599119141205868544"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599115085322285056"}], "edit_history_tweet_ids": ["1599116192475910144"], "created_at": "2022-12-03T18:59:45.000Z", "conversation_id": "1599115085322285056", "entities": {"annotations": [{"start": 127, "end": 133, "probability": 0.705, "type": "Other", "normalized_text": "Twitter"}], "mentions": [{"start": 0, "end": 13, "username": "sanamloghavi", "id": "3076847052"}, {"start": 14, "end": 23, "username": "MRLitzow", "id": "973216285"}, {"start": 24, "end": 38, "username": "SelinaLugerMD", "id": "4827569945"}, {"start": 39, "end": 53, "username": "MartinTallman", "id": "1334487799718961153"}, {"start": 54, "end": 60, "username": "eaonc", "id": "2201478360"}, {"start": 61, "end": 72, "username": "CMullighan", "id": "1579638991"}, {"start": 85, "end": 94, "username": "MRLitzow", "id": "973216285"}]}, "in_reply_to_user_id": "3076847052", "text": "@sanamloghavi @MRLitzow @SelinaLugerMD @MartinTallman @eaonc @CMullighan Congrats Dr @MRLitzow   I did not realize you were on Twitter.  Practice changing for our patients!", "lang": "en", "id": "1599116192475910144"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1599115085322285056"}], "edit_history_tweet_ids": ["1599115962238005248"], "created_at": "2022-12-03T18:58:50.000Z", "conversation_id": "1599115962238005248", "entities": {"annotations": [{"start": 70, "end": 70, "probability": 0.4981, "type": "Other", "normalized_text": "E"}, {"start": 73, "end": 79, "probability": 0.5127, "type": "Other", "normalized_text": "Paietta"}, {"start": 83, "end": 87, "probability": 0.6601, "type": "Other", "normalized_text": "Z.Sun"}], "mentions": [{"start": 3, "end": 16, "username": "sanamloghavi", "id": "3076847052"}, {"start": 30, "end": 39, "username": "MRLitzow", "id": "973216285"}, {"start": 40, "end": 54, "username": "SelinaLugerMD", "id": "4827569945"}, {"start": 55, "end": 69, "username": "MartinTallman", "id": "1334487799718961153"}, {"start": 107, "end": 113, "username": "eaonc", "id": "2201478360"}]}, "text": "RT @sanamloghavi: Congrats to @MRLitzow @SelinaLugerMD @MartinTallman E. Paietta , Z.Sun &amp; the rest of @eaonc team! This trial is one that\u2026", "lang": "en", "id": "1599115962238005248"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1599105106867212288"}], "edit_history_tweet_ids": ["1599107303172546562"], "created_at": "2022-12-03T18:24:25.000Z", "conversation_id": "1599107303172546562", "entities": {"annotations": [{"start": 56, "end": 62, "probability": 0.6683, "type": "Other", "normalized_text": "myeloma"}, {"start": 65, "end": 68, "probability": 0.4548, "type": "Other", "normalized_text": "mmsm"}], "mentions": [{"start": 3, "end": 15, "username": "HadidiSamer", "id": "774267564"}], "hashtags": [{"start": 64, "end": 69, "tag": "mmsm"}]}, "text": "RT @HadidiSamer: This study should be our role model in myeloma #mmsm \n\u2705amending protocol to give a new standard of care proven to be helpf\u2026", "lang": "en", "id": "1599107303172546562"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599103860546555905"}], "edit_history_tweet_ids": ["1599107232825999360"], "created_at": "2022-12-03T18:24:08.000Z", "conversation_id": "1598826846082121728", "entities": {"annotations": [{"start": 53, "end": 56, "probability": 0.6216, "type": "Person", "normalized_text": "Dr P"}, {"start": 63, "end": 71, "probability": 0.8641, "type": "Other", "normalized_text": "Pearl Jam"}, {"start": 88, "end": 94, "probability": 0.8439, "type": "Organization", "normalized_text": "Nirvana"}], "mentions": [{"start": 0, "end": 12, "username": "chadinabhan", "id": "2212735524"}, {"start": 13, "end": 25, "username": "GuiperiniMD", "id": "1294745239656202240"}]}, "in_reply_to_user_id": "2212735524", "text": "@chadinabhan @GuiperiniMD I am a peaceful man unless Dr P says Pearl Jam is superior to Nirvana.", "lang": "en", "id": "1599107232825999360"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599100472157011969"}], "edit_history_tweet_ids": ["1599100893177483264"], "created_at": "2022-12-03T17:58:57.000Z", "conversation_id": "1599096602895200256", "in_reply_to_user_id": "709569412370534400", "entities": {"mentions": [{"start": 0, "end": 14, "username": "smlungpathguy", "id": "709569412370534400"}]}, "text": "@smlungpathguy Beautiful", "lang": "en", "id": "1599100893177483264"}, {"entities": {"urls": [{"start": 126, "end": 149, "url": "https://t.co/egzzyRKlGs", "expanded_url": "https://tinyurl.com/254fk8bt", "display_url": "tinyurl.com/254fk8bt", "status": 200, "title": "Waldenstrom Macroglobulinemia and Hyperviscosity-related Retinopathy - EyeWiki", "description": "Waldenstrom macroglobulinemia, a type of non-Hodgkin lymphoma, is also known as lymphoplasmacytic lymphoma. ICD 10: C88.0.", "unwound_url": "https://eyewiki.aao.org/Waldenstrom_Macroglobulinemia_and_Hyperviscosity-related_Retinopathy"}, {"start": 150, "end": 173, "url": "https://t.co/3ph2UC1vsF", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599099259311513600/photo/1", "display_url": "pic.twitter.com/3ph2UC1vsF", "media_key": "3_1599099124908892160"}], "annotations": [{"start": 91, "end": 96, "probability": 0.6297, "type": "Other", "normalized_text": "Blurry"}]}, "author_id": "854692626015993857", "edit_history_tweet_ids": ["1599099259311513600"], "created_at": "2022-12-03T17:52:27.000Z", "conversation_id": "1599099259311513600", "text": "If you see a picture like this on the hematology board there is only one correct answer.\n\n\"Blurry vision\"\nTotal protein = 12\n\nhttps://t.co/egzzyRKlGs https://t.co/3ph2UC1vsF", "lang": "en", "id": "1599099259311513600"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599096928729321472"}], "edit_history_tweet_ids": ["1599098330709397504"], "created_at": "2022-12-03T17:48:46.000Z", "conversation_id": "1599093726345056256", "entities": {"annotations": [{"start": 79, "end": 88, "probability": 0.6553, "type": "Other", "normalized_text": "blina\n\nOff"}, {"start": 117, "end": 121, "probability": 0.4873, "type": "Other", "normalized_text": "GRALL"}, {"start": 148, "end": 152, "probability": 0.6476, "type": "Other", "normalized_text": "blina"}, {"start": 266, "end": 269, "probability": 0.5064, "type": "Other", "normalized_text": "AraC"}], "mentions": [{"start": 0, "end": 14, "username": "lechatnoir_89", "id": "68671526"}, {"start": 15, "end": 29, "username": "MartinTallman", "id": "1334487799718961153"}]}, "in_reply_to_user_id": "68671526", "text": "@lechatnoir_89 @MartinTallman We have a front line trial using ino followed by blina\n\nOff trial I had been using the GRALL SA01 with quick pivot to blina after some chemo.\n\nT-ALL in the elderly is hard.  IF they can tolerate it I still use hyperCVAD with lower dose AraC and lots of supportive care", "lang": "en", "id": "1599098330709397504"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "retweeted", "id": "1599097093788164097"}], "edit_history_tweet_ids": ["1599097445186965505"], "created_at": "2022-12-03T17:45:15.000Z", "conversation_id": "1599097445186965505", "entities": {"annotations": [{"start": 30, "end": 55, "probability": 0.7748, "type": "Other", "normalized_text": "Nitroblue tetrazolium test"}], "mentions": [{"start": 3, "end": 12, "username": "AdiG1993", "id": "1343430777321582593"}, {"start": 14, "end": 29, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "text": "RT @AdiG1993: @AaronGoodman33 Nitroblue tetrazolium test --&gt; some brick red colouration", "lang": "en", "id": "1599097445186965505"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599096396153425920"}], "edit_history_tweet_ids": ["1599097313976553472"], "created_at": "2022-12-03T17:44:44.000Z", "conversation_id": "1599093726345056256", "entities": {"annotations": [{"start": 164, "end": 173, "probability": 0.6621, "type": "Other", "normalized_text": "CALGB10403"}], "mentions": [{"start": 0, "end": 9, "username": "JKanerMD", "id": "782764410"}, {"start": 10, "end": 24, "username": "MartinTallman", "id": "1334487799718961153"}]}, "in_reply_to_user_id": "782764410", "text": "@JKanerMD @MartinTallman I agree.  What induction regimen will your group be using?  Will you be using what E1910 used or something else.  Our group has been using CALGB10403 for up to age 40.", "lang": "en", "id": "1599097313976553472"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599094706910003200"}], "edit_history_tweet_ids": ["1599096718997737472"], "created_at": "2022-12-03T17:42:22.000Z", "conversation_id": "1598826846082121728", "in_reply_to_user_id": "1294745239656202240", "entities": {"mentions": [{"start": 0, "end": 12, "username": "GuiperiniMD", "id": "1294745239656202240"}]}, "text": "@GuiperiniMD Will hang out. I promise I\u2019m not so bad in real life.", "lang": "en", "id": "1599096718997737472"}, {"entities": {"urls": [{"start": 197, "end": 220, "url": "https://t.co/ofWFUNzWbv", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599096602895200256/photo/1", "display_url": "pic.twitter.com/ofWFUNzWbv", "media_key": "3_1599096570447769600"}], "annotations": [{"start": 115, "end": 135, "probability": 0.5274, "type": "Person", "normalized_text": "Staph aureus\nSerratia"}, {"start": 137, "end": 144, "probability": 0.4066, "type": "Other", "normalized_text": "Nocardia"}, {"start": 146, "end": 156, "probability": 0.4396, "type": "Other", "normalized_text": "Aspergillus"}]}, "author_id": "854692626015993857", "edit_history_tweet_ids": ["1599096602895200256"], "created_at": "2022-12-03T17:41:54.000Z", "conversation_id": "1599096602895200256", "text": "It has been a while since I posted a case so here is a tough one!\n\nA 1 yo boy with recurrent infections caused by\n\nStaph aureus\nSerratia\nNocardia\nAspergillus\n\nDiagnostic test of choice?\nDiagnosis? https://t.co/ofWFUNzWbv", "lang": "en", "id": "1599096602895200256"}], "includes": {"users": [{"id": "854692626015993857", "name": "Aaron Goodman - \u201cPapa Heme\u201d", "username": "AaronGoodman33"}, {"id": "824315782947631104", "name": "Shematologist, MD", "username": "acweyand"}, {"id": "918471705408016384", "name": "Pallawi Torka", "username": "PallawiTorkaMD"}, {"id": "215681001", "name": "HemeDocRuns, MD", "username": "allisonp1979"}, {"id": "1334487799718961153", "name": "Martin S. Tallman, MD", "username": "MartinTallman"}, {"id": "1194962714", "name": "Vinay Prasad MD MPH", "username": "VPrasadMDMPH"}, {"id": "2212735524", "name": "chadi nabhan MD, MBA, FACP", "username": "chadinabhan"}, {"id": "149477915", "name": "Arjun D. Law", "username": "Haemophage"}, {"id": "719175246050410496", "name": "Andrew M. Evens, DO, MBA, MSc", "username": "DrAEvens"}, {"id": "53395744", "name": "Shernan Holtan MD", "username": "sghmd"}, {"id": "3497730012", "name": "barttels", "username": "barttels2"}, {"id": "1144997352148787201", "name": "Amer Zeidan MBBS,MHS \u200f\u0639\u0627\u0645\u0631 \u0632\u064a\u062f\u0627\u0646", "username": "Dr_AmerZeidan"}, {"id": "1269642863924609025", "name": "Manni Mohyuddin", "username": "ManniMD1"}, {"id": "626650397", "name": "Michael Slade, MD", "username": "MichaelJSlade"}, {"id": "537795028", "name": "Jonathan Reiner", "username": "JReinerMD"}, {"id": "782764410", "name": "Justin Kaner", "username": "JKanerMD"}, {"id": "18821994", "name": "David Russler-Germain, MD/PhD", "username": "dgermain21"}, {"id": "1026947037080772610", "name": "Al-Ola A Abdallah MD", "username": "Abdallah81MD"}, {"id": "3154223927", "name": "Elli Papaemmanuil, PhD", "username": "PapaemmanuilLab"}, {"id": "999010996034338818", "name": "Alan Skarbnik", "username": "ASkarbnik"}, {"id": "354168091", "name": "Matthew Mei", "username": "matthew_mei"}, {"id": "2170420038", "name": "David Young M.D.", "username": "davideyoungmd"}, {"id": "1126106500701806592", "name": "Halley Deleeuw", "username": "DeleeuwHalley"}, {"id": "913851074", "name": "Coach Bonnie", "username": "CoachBon"}, {"id": "18792477", "name": "Jean Parks", "username": "geekbabe"}, {"id": "1117857169528033280", "name": "Leonidas Platanias, MD", "username": "LeonidasPlatan1"}, {"id": "1493597471074832393", "name": "Brown Hospital Medicine", "username": "BrownHospMed"}, {"id": "28731834", "name": "Gurbakhash Kaur", "username": "GKaurMD"}, {"id": "1294745239656202240", "name": "Guilherme Perini, MD", "username": "GuiperiniMD"}, {"id": "3076847052", "name": "Sanam Loghavi, MD \u0635\u0646\u0645 \u0644\u063a\u0648\u06cc \ud83d\udd2c\ud83e\uddec", "username": "sanamloghavi"}, {"id": "709569412370534400", "name": "Sanjay Mukhopadhyay", "username": "smlungpathguy"}, {"id": "68671526", "name": "Elsa Morente", "username": "lechatnoir_89"}], "tweets": [{"entities": {"urls": [{"start": 250, "end": 273, "url": "https://t.co/Nrg0gqmJj0", "expanded_url": "https://twitter.com/jmirpub/status/1600887070377250819", "display_url": "twitter.com/jmirpub/status\u2026"}], "annotations": [{"start": 57, "end": 68, "probability": 0.7686, "type": "Other", "normalized_text": "Anne Shapiro"}], "mentions": [{"start": 36, "end": 48, "username": "AleckAmalia", "id": "1331336294828437504"}, {"start": 83, "end": 92, "username": "UCSDAnes", "id": "1542877210356330497"}, {"start": 166, "end": 178, "username": "UofCAHealth", "id": "1188993986465157120"}, {"start": 181, "end": 192, "username": "UCSDHealth", "id": "107258201"}, {"start": 193, "end": 202, "username": "UCSDnews", "id": "9233092"}, {"start": 203, "end": 218, "username": "UCSDfacaffairs", "id": "931577353351741440"}, {"start": 219, "end": 233, "username": "UCSDHealthSci", "id": "951918498560712704"}, {"start": 235, "end": 249, "username": "UCSDMedSchool", "id": "1488929426662322177"}]}, "author_id": "1542877210356330497", "referenced_tweets": [{"type": "quoted", "id": "1600887070377250819"}], "edit_history_tweet_ids": ["1601063795941482497"], "created_at": "2022-12-09T03:58:49.000Z", "conversation_id": "1601063795941482497", "text": "Congratulations to our faculty, Dr. @AleckAmalia and Dr. Anne Shapiro representing @UCSDAnes- clinical decision support to reduce anesthetic greenhouse gasses across @UofCAHealth.\n\n@UCSDHealth @UCSDnews @UCSDfacaffairs @UCSDHealthSci \n@UCSDMedSchool https://t.co/Nrg0gqmJj0", "lang": "en", "id": "1601063795941482497"}, {"entities": {"urls": [{"start": 97, "end": 120, "url": "https://t.co/3eq1rMVIZ6", "expanded_url": "https://ashpublications.org/hematology/article/2022/1/138/493499/CNS-prophylaxis-in-aggressive-B-cell-lymphoma", "display_url": "ashpublications.org/hematology/art\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1601307750147174400/2ZARgRbw?format=png&name=orig", "width": 520, "height": 675}, {"url": "https://pbs.twimg.com/news_img/1601307750147174400/2ZARgRbw?format=png&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "CNS prophylaxis in aggressive B-cell lymphoma", "description": "Abstract. The prevention of central nervous system (CNS) relapse in diffuse large B-cell lymphoma (DLBCL) continues to be one of the most contentious areas of l", "unwound_url": "https://ashpublications.org/hematology/article/2022/1/138/493499/CNS-prophylaxis-in-aggressive-B-cell-lymphoma"}, {"start": 215, "end": 238, "url": "https://t.co/3EgmpAMJsa", "expanded_url": "https://twitter.com/AaronGoodman33/status/1601300744644472832", "display_url": "twitter.com/AaronGoodman33\u2026"}], "mentions": [{"start": 17, "end": 27, "username": "sabobillo", "id": "829364688018407425"}, {"start": 28, "end": 37, "username": "CwynKate", "id": "879789995053240321"}, {"start": 141, "end": 150, "username": "CwynKate", "id": "879789995053240321"}], "hashtags": [{"start": 49, "end": 64, "tag": "CNSprophylaxis"}]}, "author_id": "45443577", "referenced_tweets": [{"type": "quoted", "id": "1601300744644472832"}], "edit_history_tweet_ids": ["1601307741355913217"], "created_at": "2022-12-09T20:08:11.000Z", "conversation_id": "1601307741355913217", "text": "Check out our (+ @sabobillo @CwynKate) review on #CNSprophylaxis in this year's educational book\nhttps://t.co/3eq1rMVIZ6\n\nTo be presented by @CwynKate in Controversies in Aggressive NHL educational session Sat 9.30 https://t.co/3EgmpAMJsa", "lang": "en", "id": "1601307741355913217"}, {"author_id": "824315782947631104", "referenced_tweets": [{"type": "replied_to", "id": "1601301419155288065"}], "edit_history_tweet_ids": ["1601301763319300096"], "created_at": "2022-12-09T19:44:25.000Z", "conversation_id": "1601285083566161922", "in_reply_to_user_id": "854692626015993857", "entities": {"mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "text": "@AaronGoodman33 Cafe du Monde?", "lang": "fr", "id": "1601301763319300096"}, {"author_id": "824315782947631104", "referenced_tweets": [{"type": "replied_to", "id": "1601285083566161922"}], "edit_history_tweet_ids": ["1601301238536028160"], "created_at": "2022-12-09T19:42:20.000Z", "conversation_id": "1601285083566161922", "in_reply_to_user_id": "854692626015993857", "entities": {"mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "text": "@AaronGoodman33 Ooh report back!", "lang": "en", "id": "1601301238536028160"}, {"entities": {"urls": [{"start": 231, "end": 254, "url": "https://t.co/JAYtA6cG0l", "expanded_url": "https://twitter.com/PallawiTorkaMD/status/1601259817154543616/photo/1", "display_url": "pic.twitter.com/JAYtA6cG0l", "media_key": "3_1601259811961819136"}], "annotations": [{"start": 17, "end": 21, "probability": 0.6422, "type": "Other", "normalized_text": "ASH22"}], "mentions": [{"start": 50, "end": 65, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 95, "end": 107, "username": "RoswellPark", "id": "16044589"}, {"start": 108, "end": 122, "username": "RoswellHemOnc", "id": "1378011784674705409"}, {"start": 144, "end": 158, "username": "HemOncFellows", "id": "1357568654444003335"}, {"start": 159, "end": 173, "username": "msalmanfaisal", "id": "141154688"}], "hashtags": [{"start": 16, "end": 22, "tag": "ASH22"}]}, "author_id": "918471705408016384", "edit_history_tweet_ids": ["1601259817154543616"], "created_at": "2022-12-09T16:57:45.000Z", "conversation_id": "1601259817154543616", "text": "Just spotted at #ASH22 \nThe brown doppelg\u00e4nger of @AaronGoodman33  \n\nOur fellow extraordinaire @RoswellPark @RoswellHemOnc and the moderator of @HemOncFellows @msalmanfaisal  \n\nYou guys need to give up your hair routine secrets. \ud83d\ude1c https://t.co/JAYtA6cG0l", "lang": "en", "id": "1601259817154543616"}, {"entities": {"urls": [{"start": 145, "end": 168, "url": "https://t.co/7fggQ0DrCd", "expanded_url": "https://ash.confex.com/ash/2022/webprogram/Paper168930.html", "display_url": "ash.confex.com/ash/2022/webpr\u2026", "status": 200, "title": "Paper: Fixed Duration Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone for High Risk Smoldering Multiple Myeloma-Results of the Ascent Trial", "description": "Program: Oral and Poster Abstracts Type: Oral Session: 653. Myeloma and Plasma Cell Dyscrasias: Prospective Therapeutic Trials: Risk-adapted Treatment Strategies in Myeloma and Related Conditions Hematology Disease Topics & Pathways: Research, clinical trials, Biological therapies, Antibody Therapy, Clinical Research, Plasma Cell Disorders, Combination therapy, Diseases, Therapies, Lymphoid Malignancies, Human, Minimal Residual Disease Shaji K Kumar, MD 1, Melissa Alsina, MD** 2, Betsy Laplant, MS 3 *,", "unwound_url": "https://ash.confex.com/ash/2022/webprogram/Paper168930.html"}, {"start": 172, "end": 195, "url": "https://t.co/rqgmPbMee8", "expanded_url": "https://ash.confex.com/ash/2022/webprogram/Paper159606.html", "display_url": "ash.confex.com/ash/2022/webpr\u2026", "status": 200, "title": "Paper: Curative Strategy (GEM-CESAR) for High-Risk Smoldering Myeloma (SMM): Post-Hoc Analysis of Sustained Undetectable Measurable Residual Disease (MRD)", "description": "Program: Oral and Poster Abstracts Type: Oral Session: 731. Autologous Transplantation: Clinical and Epidemiological: Multiple Myeloma and CHIP Hematology Disease Topics & Pathways: Clinical Practice (Health Services and Quality), Plasma Cell Disorders, Diseases, Therapies, therapy sequence, Lymphoid Malignancies, Minimal Residual Disease Maria-Victoria Mateos, MD 1, Joaqu\u00edn Mart\u00ednez-L\u00f3pez, MD, PhD 2 *, Paula Rodr\u00edguez-Otero, MD, PhD 3 *, Jes\u00fas San-Miguel, MD, PhD 4, Veronica Gonzalez-Calle, MD, PhD 1 *,", "unwound_url": "https://ash.confex.com/ash/2022/webprogram/Paper159606.html"}, {"start": 277, "end": 300, "url": "https://t.co/ikAGsUMOJo", "expanded_url": "https://twitter.com/HadidiSamer/status/1601170628899323904/photo/1", "display_url": "pic.twitter.com/ikAGsUMOJo", "media_key": "3_1601170620187918336"}], "annotations": [{"start": 113, "end": 114, "probability": 0.808, "type": "Place", "normalized_text": "US"}, {"start": 134, "end": 139, "probability": 0.8606, "type": "Place", "normalized_text": "Europe"}, {"start": 235, "end": 238, "probability": 0.381, "type": "Other", "normalized_text": "Dara"}], "hashtags": [{"start": 47, "end": 53, "tag": "ASH22"}, {"start": 90, "end": 95, "tag": "mmsm"}]}, "author_id": "774267564", "edit_history_tweet_ids": ["1601170628899323904"], "created_at": "2022-12-09T11:03:20.000Z", "conversation_id": "1601170628899323904", "text": "Let\u2019s look at 2 smoldering MM trials presented #ASH22 of from different(important) angles #mmsm \ud83e\uddf5\n\nASCENT trial (US)\nGEM-CESAR trial (Europe)\n\n\u27a1\ufe0fhttps://t.co/7fggQ0DrCd\n\u27a1\ufe0f https://t.co/rqgmPbMee8\n\nTreatment drugs and duration\ud83d\udc47\n\nASCENT:Dara-KRd(2yrs)\nGEM-CESAR:KRd+auto (~3yrs) https://t.co/ikAGsUMOJo", "lang": "en", "id": "1601170628899323904"}, {"entities": {"urls": [{"start": 197, "end": 220, "url": "https://t.co/0CTFqUnaMk", "expanded_url": "https://twitter.com/KMirza/status/1601008586108174336", "display_url": "twitter.com/KMirza/status/\u2026"}], "mentions": [{"start": 53, "end": 68, "username": "AaronGoodman33", "id": "854692626015993857"}], "hashtags": [{"start": 108, "end": 114, "tag": "ash22"}, {"start": 115, "end": 123, "tag": "ash2022"}]}, "author_id": "1194962714", "referenced_tweets": [{"type": "quoted", "id": "1601008586108174336"}], "edit_history_tweet_ids": ["1601119499625041923"], "created_at": "2022-12-09T07:40:10.000Z", "conversation_id": "1601119499625041923", "text": "So nice to top the impressions \ud83d\ude0a alongside the great @AaronGoodman33\nI will be releasing videos all through #ash22 #ash2022\nIt will be filmed on a phone selfie style.\ud83d\ude02 Hope that doesn't disappoint https://t.co/0CTFqUnaMk", "lang": "en", "id": "1601119499625041923"}, {"entities": {"urls": [{"start": 113, "end": 136, "url": "https://t.co/oqJoZwN9Df", "expanded_url": "https://twitter.com/ASkarbnik/status/1601115768598712322/photo/1", "display_url": "pic.twitter.com/oqJoZwN9Df", "media_key": "3_1601115763917692931"}], "mentions": [{"start": 30, "end": 45, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 46, "end": 58, "username": "GuiperiniMD", "id": "1294745239656202240"}, {"start": 59, "end": 71, "username": "matthew_mei", "id": "354168091"}, {"start": 72, "end": 84, "username": "smalveira23", "id": "1125437852836175874"}, {"start": 85, "end": 97, "username": "chadinabhan", "id": "2212735524"}]}, "author_id": "999010996034338818", "edit_history_tweet_ids": ["1601115768598712322"], "created_at": "2022-12-09T07:25:21.000Z", "conversation_id": "1601115768598712322", "text": "In real life we\u2019re friends \ud83d\ude09 \n@AaronGoodman33 @GuiperiniMD @matthew_mei @smalveira23 @chadinabhan where are you? https://t.co/oqJoZwN9Df", "lang": "en", "id": "1601115768598712322"}, {"author_id": "215681001", "referenced_tweets": [{"type": "replied_to", "id": "1601084075368124416"}], "edit_history_tweet_ids": ["1601098351755558913"], "created_at": "2022-12-09T06:16:08.000Z", "conversation_id": "1601084075368124416", "in_reply_to_user_id": "854692626015993857", "entities": {"mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "text": "@AaronGoodman33 What time &amp; how fast? I was gonna do 4 miles around 6 AM; 9:30 min/mile (ish)", "lang": "en", "id": "1601098351755558913"}, {"entities": {"urls": [{"start": 205, "end": 228, "url": "https://t.co/lEvpUW3Uzk", "expanded_url": "https://www.hematology.org/meetings/annual-meeting/programs/friday-scientific-workshops", "display_url": "hematology.org/meetings/annua\u2026", "status": 200, "title": "Scientific Workshops - Hematology.org", "description": "Scientific Workshops", "unwound_url": "https://www.hematology.org/meetings/annual-meeting/programs/friday-scientific-workshops"}], "annotations": [{"start": 149, "end": 153, "probability": 0.5094, "type": "Other", "normalized_text": "Ernst"}, {"start": 157, "end": 173, "probability": 0.3822, "type": "Other", "normalized_text": "Morial Convention"}, {"start": 182, "end": 192, "probability": 0.9289, "type": "Place", "normalized_text": "New Orleans"}], "mentions": [{"start": 20, "end": 26, "username": "ash22", "id": "18618457"}]}, "author_id": "3154223927", "edit_history_tweet_ids": ["1600254596235960320"], "created_at": "2022-12-06T22:23:21.000Z", "conversation_id": "1600254596235960320", "text": "Join us this Friday @ASH22 for the Molecular diagnostics &amp; Genomic reclassification of blood cancers scientific workshop. 2-5pm CET Room 298-299 Ernst N Morial Convention Center New Orleans. \ud83d\udd25 line up https://t.co/lEvpUW3Uzk", "lang": "en", "id": "1600254596235960320"}, {"author_id": "1334487799718961153", "referenced_tweets": [{"type": "replied_to", "id": "1601022306985578496"}], "edit_history_tweet_ids": ["1601036828194533377"], "created_at": "2022-12-09T02:11:40.000Z", "conversation_id": "1601020396685660160", "in_reply_to_user_id": "2212735524", "entities": {"mentions": [{"start": 0, "end": 12, "username": "chadinabhan", "id": "2212735524"}, {"start": 13, "end": 25, "username": "romeerizwan", "id": "15622046"}, {"start": 26, "end": 39, "username": "BldCancerDoc", "id": "2809497047"}, {"start": 40, "end": 51, "username": "ninashah33", "id": "1559241414"}, {"start": 52, "end": 63, "username": "Mohty_EBMT", "id": "2626263112"}, {"start": 64, "end": 79, "username": "JohnPLeonardMD", "id": "2891662867"}]}, "text": "@chadinabhan @romeerizwan @BldCancerDoc @ninashah33 @Mohty_EBMT @JohnPLeonardMD No one wants a hematologist-oncologist who looks too young!", "lang": "en", "id": "1601036828194533377"}, {"entities": {"urls": [{"start": 277, "end": 300, "url": "https://t.co/d7Ob5IqKSo", "expanded_url": "https://twitter.com/KMirza/status/1601008586108174336/photo/1", "display_url": "pic.twitter.com/d7Ob5IqKSo", "media_key": "3_1601007536970293252"}], "mentions": [{"start": 175, "end": 188, "username": "sanamloghavi", "id": "3076847052"}, {"start": 209, "end": 221, "username": "HemeReports", "id": "1481090879536439297"}, {"start": 227, "end": 242, "username": "Anand_88_Patel", "id": "2417458314"}, {"start": 243, "end": 254, "username": "doctorpemm", "id": "2429552622"}, {"start": 255, "end": 267, "username": "NitinJainMD", "id": "2756778469"}], "hashtags": [{"start": 20, "end": 26, "tag": "ASH22"}, {"start": 117, "end": 127, "tag": "PathAtASH"}, {"start": 155, "end": 165, "tag": "hemepaths"}, {"start": 268, "end": 276, "tag": "EXCITED"}]}, "author_id": "28108352", "edit_history_tweet_ids": ["1601008586108174336"], "created_at": "2022-12-09T00:19:26.000Z", "conversation_id": "1601008586108174336", "text": "&gt;56M impressions #ASH22 and it doesn't even officially start till Saturday! \ud83d\ude4c\ud83c\udffb\ud83d\ude4c\ud83c\udffb\n\nLooking forward to representing #PathAtASH soon!\n\nWhere are my fellow #hemepaths at? \ncc: @sanamloghavi \n\nAlso shout out to @hemereports team @Anand_88_Patel @doctorpemm @NitinJainMD #EXCITED https://t.co/d7Ob5IqKSo", "lang": "en", "id": "1601008586108174336"}, {"author_id": "1194962714", "edit_history_tweet_ids": ["1600958272709988352"], "created_at": "2022-12-08T20:59:31.000Z", "conversation_id": "1600958272709988352", "entities": {"annotations": [{"start": 158, "end": 162, "probability": 0.4673, "type": "Other", "normalized_text": "Ash22"}], "hashtags": [{"start": 157, "end": 163, "tag": "Ash22"}]}, "text": "Medical conferences would be more fun if it was a 4 day tournament. With winning abstracts advancing each day. So the last day is just the 10-20 best talks. #Ash22", "lang": "en", "id": "1600958272709988352"}, {"entities": {"urls": [{"start": 139, "end": 162, "url": "https://t.co/6W6O4ZpSao", "expanded_url": "https://twitter.com/DrAEvens/status/1600982180507049984/photo/1", "display_url": "pic.twitter.com/6W6O4ZpSao", "media_key": "3_1600982173858910224"}, {"start": 163, "end": 186, "url": "https://t.co/3gIH8wMnNa", "expanded_url": "https://twitter.com/aarongoodman33/status/1600900892298907648", "display_url": "twitter.com/aarongoodman33\u2026"}], "mentions": [{"start": 54, "end": 66, "username": "chadinabhan", "id": "2212735524"}, {"start": 101, "end": 116, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "author_id": "719175246050410496", "referenced_tweets": [{"type": "quoted", "id": "1600900892298907648"}], "edit_history_tweet_ids": ["1600982180507049984"], "created_at": "2022-12-08T22:34:31.000Z", "conversation_id": "1600982180507049984", "text": "And look who I find in the taxi line in Nola. \n\nSorry @chadinabhan but you have some competition for @AaronGoodman33 Papa\u2019s affection!  \ud83e\udd17\ud83e\udd17 https://t.co/6W6O4ZpSao https://t.co/3gIH8wMnNa", "lang": "en", "id": "1600982180507049984"}, {"entities": {"urls": [{"start": 60, "end": 83, "url": "https://t.co/61MHGTAQRz", "expanded_url": "https://twitter.com/chadinabhan/status/1600865250374361089", "display_url": "twitter.com/chadinabhan/st\u2026"}], "mentions": [{"start": 0, "end": 12, "username": "chadinabhan", "id": "2212735524"}, {"start": 43, "end": 58, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "author_id": "719175246050410496", "referenced_tweets": [{"type": "quoted", "id": "1600865250374361089"}], "edit_history_tweet_ids": ["1600893983668207617"], "created_at": "2022-12-08T16:44:03.000Z", "conversation_id": "1600893983668207617", "in_reply_to_user_id": "2212735524", "text": "@chadinabhan w/ unadulterated man crush on @AaronGoodman33? https://t.co/61MHGTAQRz", "lang": "en", "id": "1600893983668207617"}, {"author_id": "2212735524", "referenced_tweets": [{"type": "replied_to", "id": "1600922844849795072"}], "edit_history_tweet_ids": ["1600933603541942272"], "created_at": "2022-12-08T19:21:29.000Z", "conversation_id": "1600865250374361089", "in_reply_to_user_id": "24660850", "entities": {"mentions": [{"start": 0, "end": 9, "username": "montypal", "id": "24660850"}, {"start": 10, "end": 25, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 26, "end": 34, "username": "Nirvana", "id": "68412310"}, {"start": 35, "end": 45, "username": "ASkarbnik", "id": "999010996034338818"}, {"start": 46, "end": 52, "username": "sghmd", "id": "53395744"}, {"start": 53, "end": 65, "username": "DocsWhoRock", "id": "1266013486376726528"}, {"start": 66, "end": 78, "username": "AleckAmalia", "id": "1331336294828437504"}, {"start": 79, "end": 91, "username": "DrRanaMcKay", "id": "1113559627809996801"}]}, "text": "@montypal @AaronGoodman33 @Nirvana @ASkarbnik @sghmd @DocsWhoRock @AleckAmalia @DrRanaMcKay I wouldn\u2019t go to the extreme of super talented \nThat\u2019s an exaggeration.", "lang": "en", "id": "1600933603541942272"}, {"author_id": "149477915", "referenced_tweets": [{"type": "replied_to", "id": "1600851981702410240"}], "edit_history_tweet_ids": ["1600953322940551168"], "created_at": "2022-12-08T20:39:51.000Z", "conversation_id": "1600851981702410240", "entities": {"annotations": [{"start": 94, "end": 96, "probability": 0.5114, "type": "Organization", "normalized_text": "ASH"}], "mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 16, "end": 31, "username": "ASH_hematology", "id": "84072624"}]}, "in_reply_to_user_id": "854692626015993857", "text": "@AaronGoodman33 @ASH_hematology There will be a queue for people wanting to buy you a beer at ASH!", "lang": "en", "id": "1600953322940551168"}, {"entities": {"urls": [{"start": 252, "end": 275, "url": "https://t.co/JtAniP8cy7", "expanded_url": "https://journals.sagepub.com/doi/abs/10.1177/1049909114524477", "display_url": "journals.sagepub.com/doi/abs/10.117\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1563543025640296452/AYaJ60BC?format=jpg&name=orig", "width": 600, "height": 314}, {"url": "https://pbs.twimg.com/news_img/1563543025640296452/AYaJ60BC?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Use of the Word \u201cCure\u201d in the Oncology Literature - Vinay Prasad, 2015", "description": "Purpose: \u201cCure\u201d is an important word in oncology but its use in the published literature has not been examined. I investigated all oncology articles using cure ...", "unwound_url": "https://journals.sagepub.com/doi/abs/10.1177/1049909114524477"}], "annotations": [{"start": 117, "end": 119, "probability": 0.7727, "type": "Other", "normalized_text": "MRD"}, {"start": 245, "end": 249, "probability": 0.5851, "type": "Other", "normalized_text": "ash22"}], "hashtags": [{"start": 244, "end": 250, "tag": "ash22"}]}, "author_id": "1194962714", "edit_history_tweet_ids": ["1600907726443323392"], "created_at": "2022-12-08T17:38:40.000Z", "conversation_id": "1600907726443323392", "text": "Cure means, after a fixed course of therapy, you have the same survival as age sex matched controls\n\nIt doesn't mean MRD neg while taking many drugs, costing 600,000 a year, for the rest of your life, years and years, without proof of OS gain\n\n#ash22\n\nhttps://t.co/JtAniP8cy7", "lang": "en", "id": "1600907726443323392"}, {"author_id": "53395744", "edit_history_tweet_ids": ["1600882405812113408"], "created_at": "2022-12-08T15:58:03.000Z", "conversation_id": "1600882405812113408", "entities": {"annotations": [{"start": 7, "end": 11, "probability": 0.5701, "type": "Other", "normalized_text": "ASH22"}], "hashtags": [{"start": 6, "end": 12, "tag": "ASH22"}]}, "text": "First #ASH22 adventure: my checked bag was overweight because of all the protein I packed to consume over the next few days. Still gotta hit the macros when on the road. \ud83d\ude02\ud83c\udfcb\ufe0f\u200d\u2640\ufe0f\ud83d\udcaa", "lang": "en", "id": "1600882405812113408"}, {"author_id": "3497730012", "referenced_tweets": [{"type": "replied_to", "id": "1600865250374361089"}], "edit_history_tweet_ids": ["1600881552837091328"], "created_at": "2022-12-08T15:54:39.000Z", "conversation_id": "1600865250374361089", "entities": {"annotations": [{"start": 180, "end": 184, "probability": 0.486, "type": "Other", "normalized_text": "Aaron"}, {"start": 208, "end": 216, "probability": 0.8613, "type": "Other", "normalized_text": "Pearl Jam"}, {"start": 254, "end": 275, "probability": 0.7847, "type": "Other", "normalized_text": "PJ Stone Temple Pilots"}], "mentions": [{"start": 0, "end": 12, "username": "chadinabhan", "id": "2212735524"}, {"start": 13, "end": 28, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 29, "end": 37, "username": "Nirvana", "id": "68412310"}, {"start": 38, "end": 48, "username": "ASkarbnik", "id": "999010996034338818"}, {"start": 49, "end": 55, "username": "sghmd", "id": "53395744"}, {"start": 56, "end": 68, "username": "DocsWhoRock", "id": "1266013486376726528"}, {"start": 69, "end": 78, "username": "montypal", "id": "24660850"}, {"start": 79, "end": 91, "username": "AleckAmalia", "id": "1331336294828437504"}, {"start": 92, "end": 104, "username": "DrRanaMcKay", "id": "1113559627809996801"}]}, "in_reply_to_user_id": "2212735524", "text": "@chadinabhan @AaronGoodman33 @Nirvana @ASkarbnik @sghmd @DocsWhoRock @montypal @AleckAmalia @DrRanaMcKay I now have \ud83c\udfb6 I\u2019m so happy \ud83c\udfb6 in my head.\n\nWorse ways to start the day.\n\nHow Aaron can utterly disparage Pearl Jam but like the cheap knockoff wannabe PJ Stone Temple Pilots is beyond me, tbh.\n\n\ud83e\udd2b\ud83e\udd73", "lang": "en", "id": "1600881552837091328"}, {"entities": {"urls": [{"start": 206, "end": 229, "url": "https://t.co/pE5anOaVg9", "expanded_url": "https://www.nature.com/articles/s41408-022-00750-1", "display_url": "nature.com/articles/s4140\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1600868821236998144/O4s59sb6?format=jpg&name=orig", "width": 1970, "height": 1517}, {"url": "https://pbs.twimg.com/news_img/1600868821236998144/O4s59sb6?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015\u20132020", "description": "Blood Cancer Journal - Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015\u20132020", "unwound_url": "https://www.nature.com/articles/s41408-022-00750-1?error=cookies_not_supported&code=5043ea74-3a43-4969-85e8-fa0b6d08d74d"}, {"start": 276, "end": 299, "url": "https://t.co/pkTzoCVPbe", "expanded_url": "https://twitter.com/ManniMD1/status/1600868817608925184/photo/1", "display_url": "pic.twitter.com/pkTzoCVPbe", "media_key": "3_1600868638340239360"}], "annotations": [{"start": 19, "end": 21, "probability": 0.6415, "type": "Other", "normalized_text": "MRD"}, {"start": 37, "end": 41, "probability": 0.6262, "type": "Other", "normalized_text": "ASH22"}, {"start": 80, "end": 82, "probability": 0.6828, "type": "Other", "normalized_text": "MRD"}, {"start": 122, "end": 125, "probability": 0.5103, "type": "Other", "normalized_text": "mmsm"}], "mentions": [{"start": 231, "end": 246, "username": "rajshekharucms", "id": "140966169"}, {"start": 247, "end": 259, "username": "Eddie_Cliff", "id": "74081884"}, {"start": 260, "end": 275, "username": "AaronGoodman33", "id": "854692626015993857"}], "hashtags": [{"start": 36, "end": 42, "tag": "ASH22"}, {"start": 121, "end": 126, "tag": "mmsm"}]}, "author_id": "1269642863924609025", "edit_history_tweet_ids": ["1600868817608925184"], "created_at": "2022-12-08T15:04:03.000Z", "conversation_id": "1600868817608925184", "text": "As you prepare for MRD abstracts at #ASH22, here is our paper that explains how MRD has been used in the last 5 years of #mmsm trials, and the limitations. Thankfully, more \"actionable\" trials on the way!\n\nhttps://t.co/pE5anOaVg9\n\n@rajshekharucms @Eddie_Cliff @AaronGoodman33 https://t.co/pkTzoCVPbe", "lang": "en", "id": "1600868817608925184"}, {"entities": {"urls": [{"start": 281, "end": 304, "url": "https://t.co/EhTVwqiTG4", "expanded_url": "https://twitter.com/chadinabhan/status/1600865250374361089/video/1", "display_url": "pic.twitter.com/EhTVwqiTG4", "media_key": "7_1600865073060356097"}], "annotations": [{"start": 5, "end": 24, "probability": 0.6204, "type": "Other", "normalized_text": "HealthcareUnfiltered"}, {"start": 55, "end": 58, "probability": 0.4415, "type": "Organization", "normalized_text": "PAPA"}, {"start": 124, "end": 128, "probability": 0.6857, "type": "Other", "normalized_text": "ASH22"}], "mentions": [{"start": 60, "end": 75, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 100, "end": 108, "username": "Nirvana", "id": "68412310"}], "hashtags": [{"start": 4, "end": 25, "tag": "HealthcareUnfiltered"}, {"start": 123, "end": 129, "tag": "ASH22"}]}, "author_id": "2212735524", "edit_history_tweet_ids": ["1600865250374361089"], "created_at": "2022-12-08T14:49:52.000Z", "conversation_id": "1600865250374361089", "text": "The #HealthcareUnfiltered podcast crashed the party at PAPA @AaronGoodman33 house 2 talk guitar and @Nirvana \nThere was NO #ASH22 talk in this 7 mins video, but it\u2019s the one U must watch on your way 2 the meeting.\n\nUnedited, unfiltered, watch as things evolved.\n\nAnd yes: he sings https://t.co/EhTVwqiTG4", "lang": "en", "id": "1600865250374361089"}, {"entities": {"urls": [{"start": 82, "end": 105, "url": "https://t.co/3MBUTppjjH", "expanded_url": "https://ashpublications.org/blood/article/122/14/2302/32191/Lipogranulomatosis-and-hypersplenism-induced-by", "display_url": "ashpublications.org/blood/article/\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1600854082486296577/PDZl2PdC?format=png&name=orig", "width": 520, "height": 686}, {"url": "https://pbs.twimg.com/news_img/1600854082486296577/PDZl2PdC?format=png&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Lipogranulomatosis and hypersplenism induced by ruptured silicone breast implants", "description": "Amer M. Zeidan, Alison R. Moliterno; Lipogranulomatosis and hypersplenism induced by ruptured silicone breast implants, Blood, Volume 122, Issue 14, 3 October 2", "unwound_url": "https://ashpublications.org/blood/article/122/14/2302/32191/Lipogranulomatosis-and-hypersplenism-induced-by"}], "mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "author_id": "1144997352148787201", "referenced_tweets": [{"type": "replied_to", "id": "1600850247185354752"}], "edit_history_tweet_ids": ["1600854069664366592"], "created_at": "2022-12-08T14:05:27.000Z", "conversation_id": "1600850247185354752", "in_reply_to_user_id": "854692626015993857", "text": "@AaronGoodman33 How about this one? One of the coolest I saw during my fellowship https://t.co/3MBUTppjjH", "lang": "en", "id": "1600854069664366592"}, {"author_id": "1269642863924609025", "referenced_tweets": [{"type": "replied_to", "id": "1600685500339171330"}], "edit_history_tweet_ids": ["1600695160878223360"], "created_at": "2022-12-08T03:34:00.000Z", "conversation_id": "1600685500339171330", "in_reply_to_user_id": "419595308", "entities": {"mentions": [{"start": 0, "end": 10, "username": "HiraSMian", "id": "419595308"}]}, "text": "@HiraSMian I have full day clinic tomorrow too! \ud83d\ude41", "lang": "en", "id": "1600695160878223360"}, {"author_id": "1194962714", "referenced_tweets": [{"type": "replied_to", "id": "1600690511395758081"}], "edit_history_tweet_ids": ["1600694442427502594"], "created_at": "2022-12-08T03:31:09.000Z", "conversation_id": "1600642889280798721", "entities": {"annotations": [{"start": 149, "end": 156, "probability": 0.661, "type": "Other", "normalized_text": "mastodon"}], "mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 16, "end": 30, "username": "MichaelJSlade", "id": "626650397"}, {"start": 31, "end": 45, "username": "CyclingDoctor", "id": "23036480"}, {"start": 46, "end": 58, "username": "LabFehniger", "id": "1198731683199098881"}, {"start": 59, "end": 71, "username": "DiPersioLab", "id": "1349142172415762433"}, {"start": 72, "end": 81, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 82, "end": 96, "username": "DavidSteensma", "id": "2739065578"}, {"start": 97, "end": 107, "username": "bdermanmd", "id": "872983600416862208"}, {"start": 108, "end": 118, "username": "VincentRK", "id": "24261916"}, {"start": 119, "end": 129, "username": "myelomaMD", "id": "301568235"}, {"start": 130, "end": 139, "username": "Geoff_Uy", "id": "985139345928736768"}]}, "in_reply_to_user_id": "854692626015993857", "text": "@AaronGoodman33 @MichaelJSlade @CyclingDoctor @LabFehniger @DiPersioLab @ManniMD1 @DavidSteensma @bdermanmd @VincentRK @myelomaMD @Geoff_Uy You mean mastodon?", "lang": "en", "id": "1600694442427502594"}, {"author_id": "626650397", "edit_history_tweet_ids": ["1600642889280798721"], "created_at": "2022-12-08T00:06:17.000Z", "conversation_id": "1600642889280798721", "entities": {"annotations": [{"start": 63, "end": 69, "probability": 0.6243, "type": "Other", "normalized_text": "ASH2022"}], "mentions": [{"start": 141, "end": 155, "username": "CyclingDoctor", "id": "23036480"}, {"start": 156, "end": 168, "username": "LabFehniger", "id": "1198731683199098881"}, {"start": 169, "end": 181, "username": "DiPersioLab", "id": "1349142172415762433"}, {"start": 182, "end": 197, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 198, "end": 207, "username": "ManniMD1", "id": "1269642863924609025"}, {"start": 208, "end": 222, "username": "DavidSteensma", "id": "2739065578"}, {"start": 223, "end": 233, "username": "bdermanmd", "id": "872983600416862208"}, {"start": 234, "end": 247, "username": "VPrasadMDMPH", "id": "1194962714"}, {"start": 248, "end": 258, "username": "VincentRK", "id": "24261916"}, {"start": 259, "end": 269, "username": "myelomaMD", "id": "301568235"}, {"start": 270, "end": 279, "username": "Geoff_Uy", "id": "985139345928736768"}], "hashtags": [{"start": 62, "end": 70, "tag": "ASH2022"}]}, "text": "As a trainee who\u2019s overwhelmed by the volume of abstracts for #ASH2022, any advice on filtering/reviewing/scheduling from the senior folks?\n\n@CyclingDoctor @LabFehniger @DiPersioLab @AaronGoodman33 @ManniMD1 @DavidSteensma @bdermanmd @VPrasadMDMPH @VincentRK @myelomaMD @Geoff_Uy", "lang": "en", "id": "1600642889280798721"}, {"author_id": "537795028", "edit_history_tweet_ids": ["1600655843313213440"], "created_at": "2022-12-08T00:57:46.000Z", "conversation_id": "1600655843313213440", "entities": {"annotations": [{"start": 38, "end": 42, "probability": 0.974, "type": "Other", "normalized_text": "COVID"}]}, "text": "Like it or not we\u2019re in a significant COVID surge now. Medical meetings should require masks until this wave is over. Docs should lead by example.", "lang": "en", "id": "1600655843313213440"}, {"author_id": "782764410", "referenced_tweets": [{"type": "replied_to", "id": "1600605663356456962"}], "edit_history_tweet_ids": ["1600617014053183491"], "created_at": "2022-12-07T22:23:28.000Z", "conversation_id": "1600519646028869633", "in_reply_to_user_id": "1144997352148787201", "entities": {"mentions": [{"start": 0, "end": 14, "username": "Dr_AmerZeidan", "id": "1144997352148787201"}, {"start": 15, "end": 30, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 72, "end": 87, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "text": "@Dr_AmerZeidan @AaronGoodman33 Though I agree in principle I think what @AaronGoodman33 might be getting at is that these investigators sought to answer these ?\u2019s and they did so by well designed randomized studies. This does not, however, answer relevant clinical ?\u2019s like the ones I outlined in my responses.", "lang": "en", "id": "1600617014053183491"}, {"entities": {"urls": [{"start": 151, "end": 174, "url": "https://t.co/6Fok0TBUDi", "expanded_url": "https://ash.confex.com/ash/2022/webprogram/Paper169393.html", "display_url": "ash.confex.com/ash/2022/webpr\u2026", "status": 200, "title": "Paper: Autoimmune Diseases Are Not Associated with Monoclonal Gammopathy of Undetermined Significance: Results of the Prospective Population-Based Istopmm Study", "description": "Program: Oral and Poster Abstracts Session: 652. Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster III Hematology Disease Topics & Pathways: adult, Research, epidemiology, Plasma Cell Disorders, Clinical Research, Diseases, Lymphoid Malignancies, Human, Study Population Ingigerdur S Sverrisdottir, MD 1,2 *, Sigr\u00fan Thorsteinsd\u00f3ttir, MD, PhD 2,3, S\u00e6mundur R\u00f6gnvaldsson, MD 4 *, Thor Aspelund, PhD 2 *, Brynjar Vidarsson, MD 5, P\u00e1ll Torfi \u00d6nundarson, MD 5 *, Bjarni Agnarsson, MD", "unwound_url": "https://ash.confex.com/ash/2022/webprogram/Paper169393.html"}, {"start": 246, "end": 269, "url": "https://t.co/QUlXawKR7Z", "expanded_url": "https://twitter.com/ManniMD1/status/1600545405540126720/photo/1", "display_url": "pic.twitter.com/QUlXawKR7Z", "media_key": "3_1600545179307425792"}], "annotations": [{"start": 231, "end": 235, "probability": 0.6187, "type": "Other", "normalized_text": "ASH22"}], "mentions": [{"start": 125, "end": 133, "username": "iStopMM", "id": "844232399319941122"}, {"start": 134, "end": 148, "username": "sykristinsson", "id": "3078258341"}], "hashtags": [{"start": 230, "end": 236, "tag": "ASH22"}]}, "author_id": "1269642863924609025", "edit_history_tweet_ids": ["1600545405540126720"], "created_at": "2022-12-07T17:38:56.000Z", "conversation_id": "1600545405540126720", "text": "The title of my talk today to rheumatologists, we are already changing practice and minds as a result of the amazing work by @iStopMM @sykristinsson \n\nhttps://t.co/6Fok0TBUDi\n\nAn example of practice changed even before the actual #ASH22 meeting! https://t.co/QUlXawKR7Z", "lang": "en", "id": "1600545405540126720"}, {"entities": {"urls": [{"start": 261, "end": 284, "url": "https://t.co/sKNJ3DN7sU", "expanded_url": "https://twitter.com/AaronGoodman33/status/1600261398268764160/photo/1", "display_url": "pic.twitter.com/sKNJ3DN7sU", "media_key": "3_1600260629113077760"}, {"start": 285, "end": 308, "url": "https://t.co/ewKqTmAQ1u", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599925397139099648", "display_url": "twitter.com/AaronGoodman33\u2026"}], "annotations": [{"start": 1, "end": 5, "probability": 0.6249, "type": "Other", "normalized_text": "ASH22"}, {"start": 151, "end": 154, "probability": 0.7166, "type": "Other", "normalized_text": "HSCT"}], "hashtags": [{"start": 0, "end": 6, "tag": "ASH22"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "quoted", "id": "1599925397139099648"}], "edit_history_tweet_ids": ["1600261398268764160"], "created_at": "2022-12-06T22:50:23.000Z", "conversation_id": "1600261398268764160", "text": "#ASH22 Practice Changers\n\nTime to abolish for good the neutropenic diet!\nLet patients with cancer eat what ever they want even if neutropenic.\n\nRCT in HSCT or induction chemo pts\nRandomized 1:1 to standard diet or protective diet.\n\nNo difference in infections! https://t.co/sKNJ3DN7sU https://t.co/ewKqTmAQ1u", "lang": "en", "id": "1600261398268764160"}, {"entities": {"urls": [{"start": 244, "end": 267, "url": "https://t.co/hMfWRSn6tN", "expanded_url": "https://ash.confex.com/ash/2022/webprogram/Paper169533.html", "display_url": "ash.confex.com/ash/2022/webpr\u2026", "status": 200, "title": "Paper: Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+Treated with Daratumumab-Based Regimens: A Retrospective Analysis", "description": "Program: Oral and Poster Abstracts Session: 652. Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster II Ricardo D Parrondo, MD 1, Lindsay Brooke Gardner, MS, MD 1, Mohamad Alhaj Moustafa, MD 1, Vivek Roy, MD 2, Taimur Sher, MD 1, Ahsan Rasheed 2 *, Rahma M Warsame, MD 3, Jeremy T. Larsen 4 *, Wilson I. Gonsalves, MD 5, Taxiarchis Kourelis, MD 5, Prashant Kapoor, MD 3, Rafael Fonseca, MD 4, Asher Chanan-Khan, MD 2 and Sikander Ailawadhi 6 1 Division of Hematology and Medical", "unwound_url": "https://ash.confex.com/ash/2022/webprogram/Paper169533.html"}], "annotations": [{"start": 96, "end": 102, "probability": 0.6041, "type": "Other", "normalized_text": "myeloma"}, {"start": 114, "end": 124, "probability": 0.4996, "type": "Other", "normalized_text": "daratumumab"}, {"start": 141, "end": 144, "probability": 0.4638, "type": "Other", "normalized_text": "Mayo"}, {"start": 165, "end": 165, "probability": 0.5268, "type": "Other", "normalized_text": "-"}], "hashtags": [{"start": 269, "end": 275, "tag": "ASH22"}]}, "author_id": "1269642863924609025", "edit_history_tweet_ids": ["1600478408659517440"], "created_at": "2022-12-07T13:12:42.000Z", "conversation_id": "1600478408659517440", "text": "The presence or absence of gain1q did not change outcomes in a cohort of patients with relapsed myeloma receiving daratumumab- data from the Mayo dataset.\n\nIMO- Anti-CD38 therapy similarly effective in gain1q, whether you choose isa or dara. \n\nhttps://t.co/hMfWRSn6tN\n\n#ASH22", "lang": "en", "id": "1600478408659517440"}, {"entities": {"urls": [{"start": 149, "end": 172, "url": "https://t.co/5sw3fwWNsx", "expanded_url": "https://ashpublications.org/bloodadvances/article/6/22/5811/485287/Safety-and-efficacy-of-a-dose-dense-short-term?utm_source=&utm_medium=&utm_campaign=highlights_12_6_22&utm_source=sfmc&utm_medium=email&utm_campaign=BA+Highlights_12_6_22&utm_term=Link+Text", "display_url": "ashpublications.org/bloodadvances/\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1599788273773121537/xXGO_tPi?format=png&name=orig", "width": 520, "height": 685}, {"url": "https://pbs.twimg.com/news_img/1599788273773121537/xXGO_tPi?format=png&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma", "description": "Key Points. CARMEN regimen includes single doses of drugs delivered in 81 days (median), with good tolerability and lower risk of late toxicity.A 5-year OS of \u223c", "unwound_url": "https://ashpublications.org/bloodadvances/article/6/22/5811/485287/Safety-and-efficacy-of-a-dose-dense-short-term?utm_source=&utm_medium=&utm_campaign=highlights_12_6_22&utm_source=sfmc&utm_medium=email&utm_campaign=BA+Highlights_12_6_22&utm_term=Link+Text"}], "annotations": [{"start": 57, "end": 59, "probability": 0.5132, "type": "Organization", "normalized_text": "MYC"}, {"start": 79, "end": 81, "probability": 0.7652, "type": "Organization", "normalized_text": "NHL"}, {"start": 92, "end": 96, "probability": 0.5451, "type": "Other", "normalized_text": "RCHOP"}], "mentions": [{"start": 21, "end": 35, "username": "BloodAdvances", "id": "732570175162179585"}, {"start": 107, "end": 117, "username": "ASkarbnik", "id": "999010996034338818"}, {"start": 118, "end": 130, "username": "GuiperiniMD", "id": "1294745239656202240"}, {"start": 131, "end": 146, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "author_id": "2212735524", "edit_history_tweet_ids": ["1600467379158294528"], "created_at": "2022-12-07T12:28:53.000Z", "conversation_id": "1600467379158294528", "text": "Interesting study in @BloodAdvances but are you treating MYC-only translocated NHL with non-RCHOP program?\n@ASkarbnik @GuiperiniMD @AaronGoodman33 \n\nhttps://t.co/5sw3fwWNsx+\u00bb&amp;utm_id=212692&amp;sfmc_id=19415589", "lang": "en", "id": "1600467379158294528"}, {"entities": {"urls": [{"start": 122, "end": 145, "url": "https://t.co/I6Wg2rP9n7", "expanded_url": "https://twitter.com/AaronGoodman33/status/1600261398268764160", "display_url": "twitter.com/AaronGoodman33\u2026"}], "annotations": [{"start": 118, "end": 120, "probability": 0.8958, "type": "Organization", "normalized_text": "ANC"}]}, "author_id": "807337182", "referenced_tweets": [{"type": "quoted", "id": "1600261398268764160"}], "edit_history_tweet_ids": ["1600283901821583360"], "created_at": "2022-12-07T00:19:48.000Z", "conversation_id": "1600283901821583360", "text": "Of the many miseries endured by patients  in the hospital one of them is the needlessly restrictive diet \ud83d\udc47\ud83c\udffb p.o. &gt; ANC https://t.co/I6Wg2rP9n7", "lang": "en", "id": "1600283901821583360"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600320621426397184"}], "edit_history_tweet_ids": ["1600321063426326528"], "created_at": "2022-12-07T02:47:28.000Z", "conversation_id": "1600320621426397184", "in_reply_to_user_id": "1269642863924609025", "entities": {"mentions": [{"start": 0, "end": 9, "username": "ManniMD1", "id": "1269642863924609025"}]}, "text": "@ManniMD1 But perhaps the only true cure?", "lang": "en", "id": "1600321063426326528"}, {"entities": {"urls": [{"start": 239, "end": 262, "url": "https://t.co/TRmA2IIBMa", "expanded_url": "https://ash.confex.com/ash/2022/webprogram/Paper156078.html", "display_url": "ash.confex.com/ash/2022/webpr\u2026", "status": 200, "title": "Paper: Outcomes of Allogeneic Stem Cell Transplant for Multiple Myeloma", "description": "Program: Oral and Poster Abstracts Session: 652. Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Poster II Hematology Disease Topics & Pathways: Research, Biological therapies, Clinical Research, health outcomes research, Therapies, Transplantation 1 Mayo Clinic Alix School of Medicine, Rochester, MN 2 Mayo clinic college of medicine, Rochester, MN 3 Division of Hematology, Mayo Clinic, Rochester, MN 4 Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester", "unwound_url": "https://ash.confex.com/ash/2022/webprogram/Paper156078.html"}, {"start": 278, "end": 301, "url": "https://t.co/KDYAfJRqgU", "expanded_url": "https://twitter.com/ManniMD1/status/1600320621426397184/photo/1", "display_url": "pic.twitter.com/KDYAfJRqgU", "media_key": "3_1600320617927958528"}], "annotations": [{"start": 66, "end": 85, "probability": 0.6851, "type": "Other", "normalized_text": "myeloma- Mayo Clinic"}, {"start": 265, "end": 268, "probability": 0.4892, "type": "Other", "normalized_text": "mmsm"}], "hashtags": [{"start": 264, "end": 269, "tag": "mmsm"}, {"start": 271, "end": 277, "tag": "ASH22"}]}, "author_id": "1269642863924609025", "edit_history_tweet_ids": ["1600320621426397184"], "created_at": "2022-12-07T02:45:43.000Z", "conversation_id": "1600320621426397184", "text": "Good reminder of limited role of allogenic transplant in multiple myeloma- Mayo Clinic experience\n\nN=89\nLong term survival in less than 20%\nBy 2 years, 75% pts either progressed or died\n\nCaveat:most patients at relapse, not 1st remission\n\nhttps://t.co/TRmA2IIBMa\n\n#mmsm \n#ASH22 https://t.co/KDYAfJRqgU", "lang": "en", "id": "1600320621426397184"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1600313165601857539"}], "edit_history_tweet_ids": ["1600320182240522240"], "created_at": "2022-12-07T02:43:58.000Z", "conversation_id": "1600313165601857539", "entities": {"annotations": [{"start": 27, "end": 39, "probability": 0.877, "type": "Other", "normalized_text": "Cafe Du Monde"}], "mentions": [{"start": 0, "end": 9, "username": "acweyand", "id": "824315782947631104"}, {"start": 14, "end": 26, "username": "AleckAmalia", "id": "1331336294828437504"}]}, "in_reply_to_user_id": "824315782947631104", "text": "@acweyand Per @AleckAmalia Cafe Du Monde.  I will be going their daily.", "lang": "en", "id": "1600320182240522240"}, {"author_id": "824315782947631104", "edit_history_tweet_ids": ["1600313165601857539"], "created_at": "2022-12-07T02:16:05.000Z", "conversation_id": "1600313165601857539", "entities": {"annotations": [{"start": 49, "end": 53, "probability": 0.7102, "type": "Other", "normalized_text": "ASH22"}, {"start": 90, "end": 100, "probability": 0.992, "type": "Place", "normalized_text": "New Orleans"}], "hashtags": [{"start": 48, "end": 54, "tag": "ASH22"}]}, "text": "But seriously, the most important questions re: #ASH22 are where are the best beignets in New Orleans and how many times a day is acceptable to eat them?", "lang": "en", "id": "1600313165601857539"}, {"author_id": "18821994", "referenced_tweets": [{"type": "replied_to", "id": "1600296136417619968"}], "edit_history_tweet_ids": ["1600297330946678784"], "created_at": "2022-12-07T01:13:10.000Z", "conversation_id": "1600254596235960320", "in_reply_to_user_id": "854692626015993857", "entities": {"mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 16, "end": 32, "username": "PapaemmanuilLab", "id": "3154223927"}, {"start": 33, "end": 39, "username": "ash22", "id": "18618457"}]}, "text": "@AaronGoodman33 @PapaemmanuilLab @ash22 Same!", "lang": "en", "id": "1600297330946678784"}, {"author_id": "1026947037080772610", "edit_history_tweet_ids": ["1600296085209202688"], "created_at": "2022-12-07T01:08:13.000Z", "conversation_id": "1600296085209202688", "entities": {"annotations": [{"start": 65, "end": 71, "probability": 0.5885, "type": "Other", "normalized_text": "myeloma"}, {"start": 104, "end": 114, "probability": 0.8093, "type": "Other", "normalized_text": "Daratumumab"}, {"start": 133, "end": 142, "probability": 0.8277, "type": "Other", "normalized_text": "Isatuximab"}, {"start": 260, "end": 263, "probability": 0.5008, "type": "Other", "normalized_text": "mmsm"}], "hashtags": [{"start": 259, "end": 264, "tag": "mmsm"}]}, "text": "When a recommendation from a knowledgeable oncologist to treat a myeloma patient with maintenance using Daratumumab alternating with Isatuximab (to overcome 1q and decrease the incidence of resistance)! Then all I have to say this is a different level of BS! #mmsm", "lang": "en", "id": "1600296085209202688"}, {"entities": {"urls": [{"start": 290, "end": 313, "url": "https://t.co/btoPwYi8KK", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599925397139099648/photo/1", "display_url": "pic.twitter.com/btoPwYi8KK", "media_key": "3_1599925066690502656"}, {"start": 314, "end": 337, "url": "https://t.co/pG7exZwa7f", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599093726345056256", "display_url": "twitter.com/AaronGoodman33\u2026"}], "annotations": [{"start": 53, "end": 63, "probability": 0.5267, "type": "Other", "normalized_text": "Mantle Cell"}, {"start": 94, "end": 98, "probability": 0.5004, "type": "Other", "normalized_text": "RCHOP"}, {"start": 100, "end": 103, "probability": 0.5465, "type": "Other", "normalized_text": "DHAP"}, {"start": 107, "end": 115, "probability": 0.5074, "type": "Other", "normalized_text": "ibrutinib"}, {"start": 129, "end": 133, "probability": 0.505, "type": "Other", "normalized_text": "RCHOP"}, {"start": 135, "end": 138, "probability": 0.4628, "type": "Other", "normalized_text": "DHAP"}, {"start": 165, "end": 169, "probability": 0.481, "type": "Other", "normalized_text": "RCHOP"}, {"start": 171, "end": 174, "probability": 0.508, "type": "Other", "normalized_text": "DHAP"}, {"start": 275, "end": 283, "probability": 0.5558, "type": "Other", "normalized_text": "ibrutinib"}], "hashtags": [{"start": 0, "end": 6, "tag": "ASH22"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "quoted", "id": "1599093726345056256"}], "edit_history_tweet_ids": ["1599925397139099648"], "created_at": "2022-12-06T00:35:14.000Z", "conversation_id": "1599925397139099648", "text": "#ASH22 Practice Changers\n\nTriangle study!\n\nFrontline Mantle Cell\nTransplant eligible\n\n3 arms*\nRCHOP/DHAP + ibrutinib-&gt;I maint\nRCHOP/DHAP + I-&gt;ASCT-&gt;I maint\nRCHOP/DHAP-&gt;ASCT\n*ritux maint allowed\n\nFFS equal in ibrutinib arms regardless of ASCT or not\n\nCan \ud83d\udeabASCT if ibrutinib used https://t.co/btoPwYi8KK https://t.co/pG7exZwa7f", "lang": "en", "id": "1599925397139099648"}, {"author_id": "999010996034338818", "referenced_tweets": [{"type": "replied_to", "id": "1600201643785539584"}], "edit_history_tweet_ids": ["1600202096393224193"], "created_at": "2022-12-06T18:54:44.000Z", "conversation_id": "1599065279786409985", "entities": {"annotations": [{"start": 119, "end": 124, "probability": 0.9125, "type": "Organization", "normalized_text": "Eagles"}], "mentions": [{"start": 0, "end": 12, "username": "matthew_mei", "id": "354168091"}, {"start": 13, "end": 25, "username": "GuiperiniMD", "id": "1294745239656202240"}, {"start": 26, "end": 39, "username": "paulocruzphi", "id": "1913011345"}, {"start": 51, "end": 63, "username": "GuiperiniMD", "id": "1294745239656202240"}]}, "in_reply_to_user_id": "354168091", "text": "@matthew_mei @GuiperiniMD @paulocruzphi Don\u2019t mind @GuiperiniMD , he only pretends he knows music, while thinking that Eagles is the best band ever.", "lang": "en", "id": "1600202096393224193"}, {"author_id": "354168091", "referenced_tweets": [{"type": "replied_to", "id": "1599946249528291330"}], "edit_history_tweet_ids": ["1599947443327893504"], "created_at": "2022-12-06T02:02:50.000Z", "conversation_id": "1599925397139099648", "entities": {"annotations": [{"start": 68, "end": 72, "probability": 0.5503, "type": "Other", "normalized_text": "Thurs"}], "mentions": [{"start": 0, "end": 10, "username": "ASkarbnik", "id": "999010996034338818"}, {"start": 11, "end": 26, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 27, "end": 39, "username": "GuiperiniMD", "id": "1294745239656202240"}]}, "in_reply_to_user_id": "999010996034338818", "text": "@ASkarbnik @AaronGoodman33 @GuiperiniMD Either of you guys there on Thurs?", "lang": "en", "id": "1599947443327893504"}, {"author_id": "854692626015993857", "referenced_tweets": [{"type": "replied_to", "id": "1599941573659463680"}], "edit_history_tweet_ids": ["1599942610046824449"], "created_at": "2022-12-06T01:43:38.000Z", "conversation_id": "1599925397139099648", "entities": {"annotations": [{"start": 258, "end": 262, "probability": 0.7584, "type": "Other", "normalized_text": "SHINE"}], "mentions": [{"start": 0, "end": 12, "username": "matthew_mei", "id": "354168091"}, {"start": 13, "end": 25, "username": "GuiperiniMD", "id": "1294745239656202240"}, {"start": 26, "end": 36, "username": "ASkarbnik", "id": "999010996034338818"}]}, "in_reply_to_user_id": "354168091", "text": "@matthew_mei @GuiperiniMD @ASkarbnik This study gets rid of one toxic therapy (auto) and replaces with something else.  SHINE just adds therapy we know works.\n\nNeither are truly practice changing if you read my attached tweet although this study better than SHINE which just confirmed the obvious.", "lang": "en", "id": "1599942610046824449"}, {"author_id": "354168091", "referenced_tweets": [{"type": "replied_to", "id": "1599941390443479041"}], "edit_history_tweet_ids": ["1599941573659463680"], "created_at": "2022-12-06T01:39:31.000Z", "conversation_id": "1599925397139099648", "entities": {"annotations": [{"start": 54, "end": 58, "probability": 0.6184, "type": "Other", "normalized_text": "SHINE"}], "mentions": [{"start": 0, "end": 12, "username": "GuiperiniMD", "id": "1294745239656202240"}, {"start": 13, "end": 23, "username": "ASkarbnik", "id": "999010996034338818"}, {"start": 24, "end": 39, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "in_reply_to_user_id": "1294745239656202240", "text": "@GuiperiniMD @ASkarbnik @AaronGoodman33 Haha -- yeah, SHINE got trashed and this is plenary.  Make it make sense", "lang": "en", "id": "1599941573659463680"}, {"author_id": "2170420038", "referenced_tweets": [{"type": "replied_to", "id": "1599925397139099648"}], "edit_history_tweet_ids": ["1599930810962182144"], "created_at": "2022-12-06T00:56:45.000Z", "conversation_id": "1599925397139099648", "entities": {"annotations": [{"start": 27, "end": 35, "probability": 0.7703, "type": "Other", "normalized_text": "HyperCVAD"}, {"start": 39, "end": 43, "probability": 0.4938, "type": "Other", "normalized_text": "HDmtx"}, {"start": 142, "end": 144, "probability": 0.4184, "type": "Organization", "normalized_text": "BTK"}, {"start": 182, "end": 190, "probability": 0.6879, "type": "Other", "normalized_text": "Ibrutinib"}], "mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "in_reply_to_user_id": "854692626015993857", "text": "@AaronGoodman33 Where does HyperCVAD / HDmtx-HD-cyt factor in?  Is that better than the outpatient recipe, or the same?  And what about other BTK inhibitors that \"may\" be safer than Ibrutinib?", "lang": "en", "id": "1599930810962182144"}, {"entities": {"urls": [{"start": 188, "end": 211, "url": "https://t.co/KQS9Cxbfig", "expanded_url": "https://ashpublications.org/bloodadvances/article/6/18/5285/484992/Bendamustine-or-high-dose-cytarabine-based", "display_url": "ashpublications.org/bloodadvances/\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1599929916271005696/ZfuMNMfg?format=png&name=orig", "width": 520, "height": 681}, {"url": "https://pbs.twimg.com/news_img/1599929916271005696/ZfuMNMfg?format=png&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma", "description": "Key Points. R-B with ASCT and MR is a feasible first-line strategy for younger, transplant-eligible patients with MCL.R-B with ASCT and MR achieves outcomes com", "unwound_url": "https://ashpublications.org/bloodadvances/article/6/18/5285/484992/Bendamustine-or-high-dose-cytarabine-based"}], "annotations": [{"start": 58, "end": 61, "probability": 0.3818, "type": "Other", "normalized_text": "DHAP"}, {"start": 111, "end": 119, "probability": 0.4918, "type": "Other", "normalized_text": "ibrutinib"}], "mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "author_id": "354168091", "referenced_tweets": [{"type": "replied_to", "id": "1599925397139099648"}], "edit_history_tweet_ids": ["1599929906628284416"], "created_at": "2022-12-06T00:53:09.000Z", "conversation_id": "1599925397139099648", "in_reply_to_user_id": "854692626015993857", "text": "@AaronGoodman33 And BR + ASCT looks similar to R-CHOP / R-DHAP + ASCT ... by the transitive property then BR + ibrutinib wins right?  So SHINE after all?  (Btw this is in jest obviously)  https://t.co/KQS9Cxbfig", "lang": "en", "id": "1599929906628284416"}, {"entities": {"urls": [{"start": 257, "end": 280, "url": "https://t.co/2MZgWt2YNT", "expanded_url": "https://tinyurl.com/5n7vunmn", "display_url": "tinyurl.com/5n7vunmn", "status": 200, "title": "Paper: Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil As the New Standard for Graft-Versus-Host Disease (GVHD) Prophylaxis in Reduced Intensity Conditioning: Results from Phase III BMT CTN 1703", "description": "Program: General Sessions Session: Late-Breaking Abstracts Session Hematology Disease Topics & Pathways: adult, Research, clinical trials, Non-Biological therapies, Clinical Research, Chemotherapy, Therapies, immunology, Adverse Events, Biological Processes, Human, Study Population Shernan G Holtan, MD 1, Mehdi Hamadani, MD 2, Juan WU 3 *, Monzr M. AL Malki, MD 4, Lyndsey Runaas, MD 5 *, Hany Elmariah, MD, MS 6, Andrew R. Rezvani, MD 7, Mahasweta Gooptu, MD 8, Karilyn T. Larkin, MD 9, Brian C. Shaffer, MD", "unwound_url": "https://ash.confex.com/ash/2022/webprogram/Paper171463.html"}, {"start": 281, "end": 304, "url": "https://t.co/4UvkuJsdY2", "expanded_url": "https://twitter.com/AaronGoodman33/status/1598728138812710912/photo/1", "display_url": "pic.twitter.com/4UvkuJsdY2", "media_key": "3_1598727191889469440"}], "annotations": [{"start": 38, "end": 42, "probability": 0.5499, "type": "Other", "normalized_text": "ASH22"}, {"start": 91, "end": 96, "probability": 0.6744, "type": "Other", "normalized_text": "BMTCTN"}], "mentions": [{"start": 124, "end": 130, "username": "sghmd", "id": "53395744"}], "hashtags": [{"start": 37, "end": 43, "tag": "ASH22"}]}, "author_id": "854692626015993857", "edit_history_tweet_ids": ["1598728138812710912"], "created_at": "2022-12-02T17:17:45.000Z", "conversation_id": "1598728138812710912", "text": "I will be sharing over next few days #ASH22 abstracts that are practice changing for me! \n\nBMTCTN 1703 by legendary bassist @sghmd \n\nRIC sib/MUD allo\nPeripheral blood donor\nPTCy/Tac/MMF vs Tac/MTX \n\n1-yr GRFS 52.7% for PTCy vs 34.9%\n\u2b07\ufe0facute+chronic GVHD! \n\nhttps://t.co/2MZgWt2YNT https://t.co/4UvkuJsdY2", "lang": "en", "id": "1598728138812710912"}, {"entities": {"urls": [{"start": 263, "end": 286, "url": "https://t.co/SMATmfygre", "expanded_url": "https://tinyurl.com/4kapaavz", "display_url": "tinyurl.com/4kapaavz", "status": 200, "title": "Paper: Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Networ", "description": "Program: General Sessions Session: Late-Breaking Abstracts Session Hematology Disease Topics & Pathways: ALL, Biological therapies, Lymphoid Leukemias, Clinical Practice (Health Services and Quality), Bispecific Antibody Therapy, Diseases, Therapies, Lymphoid Malignancies 1 Division of Hemat ology, Mayo Clinic, Rochester, MN 2 Dana-Farber Cancer Institute, Boston, MA 3 Cancer Center, Montefiore Medical Center, Bronx, NY 4 Carbone Comprehensive Cancer Center, Madison, WI 5 Adult Hematologic Malignancies &", "unwound_url": "https://ash.confex.com/ash/2022/webprogram/Paper171751.html"}, {"start": 287, "end": 310, "url": "https://t.co/sKerPuX21E", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599093726345056256/photo/1", "display_url": "pic.twitter.com/sKerPuX21E", "media_key": "3_1599091253223645184"}, {"start": 311, "end": 334, "url": "https://t.co/fiIEslO14i", "expanded_url": "https://twitter.com/AaronGoodman33/status/1598728138812710912", "display_url": "twitter.com/AaronGoodman33\u2026"}], "annotations": [{"start": 173, "end": 184, "probability": 0.5868, "type": "Other", "normalized_text": "blinatumomab"}, {"start": 201, "end": 205, "probability": 0.4542, "type": "Other", "normalized_text": "Blina"}], "mentions": [{"start": 32, "end": 46, "username": "MartinTallman", "id": "1334487799718961153"}], "hashtags": [{"start": 0, "end": 6, "tag": "ASH22"}]}, "author_id": "854692626015993857", "referenced_tweets": [{"type": "quoted", "id": "1598728138812710912"}], "edit_history_tweet_ids": ["1599093726345056256"], "created_at": "2022-12-03T17:30:28.000Z", "conversation_id": "1599093726345056256", "text": "#ASH22 Practice Changers\n\nE1910 @MartinTallman\n\nPh- B-ALL (30-70 yo) \nBFM-like induction [PEG if&lt;55 yo,ritux if CD20+]\n\ns/p intensification MRD-(&lt;0.01%) randomized to blinatumomab+chemo vs chemo\nBlina arm superior OS\n\nMy practice = blina for MRD+ and MRD-\n\nhttps://t.co/SMATmfygre https://t.co/sKerPuX21E https://t.co/fiIEslO14i", "lang": "en", "id": "1599093726345056256"}, {"entities": {"urls": [{"start": 208, "end": 231, "url": "https://t.co/mmiGmXbiUG", "expanded_url": "https://twitter.com/ManniMD1/status/1590440063263182851", "display_url": "twitter.com/ManniMD1/statu\u2026"}], "annotations": [{"start": 1, "end": 5, "probability": 0.6643, "type": "Other", "normalized_text": "ASH22"}, {"start": 117, "end": 123, "probability": 0.7147, "type": "Other", "normalized_text": "myeloma"}, {"start": 203, "end": 206, "probability": 0.4725, "type": "Other", "normalized_text": "mmsm"}], "hashtags": [{"start": 0, "end": 6, "tag": "ASH22"}, {"start": 202, "end": 207, "tag": "mmsm"}]}, "author_id": "1269642863924609025", "referenced_tweets": [{"type": "quoted", "id": "1590440063263182851"}], "edit_history_tweet_ids": ["1599779550753193985"], "created_at": "2022-12-05T14:55:42.000Z", "conversation_id": "1599779550753193985", "text": "#ASH22 starts this week.\n\nHere is a list of top 10 abstracts that have already influenced my thought and practice in myeloma! Look forward to hearing more about these and other studies at the meeting!\n\n#mmsm https://t.co/mmiGmXbiUG", "lang": "en", "id": "1599779550753193985"}, {"author_id": "1194962714", "referenced_tweets": [{"type": "replied_to", "id": "1599868146663690240"}], "edit_history_tweet_ids": ["1599872039862824960"], "created_at": "2022-12-05T21:03:13.000Z", "conversation_id": "1599859955275735040", "in_reply_to_user_id": "854692626015993857", "entities": {"mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "text": "@AaronGoodman33 Cancer groups would be stronger if they actually addressed some of the legitimate criticism about the high price, and skewed research agenda. Hope they do!", "lang": "en", "id": "1599872039862824960"}, {"entities": {"urls": [{"start": 251, "end": 274, "url": "https://t.co/bVnafQJHvg", "expanded_url": "https://www.youtube.com/watch?v=jAz84yCnfjQ&t=22", "display_url": "youtube.com/watch?v=jAz84y\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1599859959172210688/ES5stYKW?format=jpg&name=orig", "width": 1280, "height": 720}, {"url": "https://pbs.twimg.com/news_img/1599859959172210688/ES5stYKW?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "What Questions are Current Myeloma Trials NOT Answering | Invited Talk to UK Myeloma Research Day", "description": "A link to our paper that I didn't mention but should havehttps://ashpublications.org/blood/article/137/4/456/474255/Persistent-challenges-with-treating-multi...", "unwound_url": "https://www.youtube.com/watch?v=jAz84yCnfjQ&t=22"}, {"start": 275, "end": 298, "url": "https://t.co/kGzDBr3xog", "expanded_url": "https://twitter.com/VPrasadMDMPH/status/1599859955275735040/photo/1", "display_url": "pic.twitter.com/kGzDBr3xog", "media_key": "3_1599859502668316672"}], "annotations": [{"start": 69, "end": 70, "probability": 0.7695, "type": "Place", "normalized_text": "UK"}, {"start": 72, "end": 87, "probability": 0.6183, "type": "Other", "normalized_text": "Myeloma Research"}]}, "author_id": "1194962714", "edit_history_tweet_ids": ["1599859955275735040"], "created_at": "2022-12-05T20:15:11.000Z", "conversation_id": "1599859955275735040", "text": "It was great to get this feedback from the packed auditorium for the UK Myeloma Research day\ud83d\udc47\ud83d\udc47\n\nBecause of the magic of technology, you can watch the lecture they heard! \n\nIn case interested, I would be happy to debate any of the arguments in the vid\nhttps://t.co/bVnafQJHvg https://t.co/kGzDBr3xog", "lang": "en", "id": "1599859955275735040"}, {"entities": {"urls": [{"start": 236, "end": 259, "url": "https://t.co/WtFwkcYCg1", "expanded_url": "https://twitter.com/AaronGoodman33/status/1598819684610347014", "display_url": "twitter.com/AaronGoodman33\u2026"}], "annotations": [{"start": 145, "end": 150, "probability": 0.4904, "type": "Other", "normalized_text": "cancer"}], "mentions": [{"start": 15, "end": 30, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 92, "end": 98, "username": "Optum", "id": "318007077"}]}, "author_id": "1269642863924609025", "referenced_tweets": [{"type": "quoted", "id": "1598819684610347014"}], "edit_history_tweet_ids": ["1599826784786477057"], "created_at": "2022-12-05T18:03:23.000Z", "conversation_id": "1599826784786477057", "text": "You were right @AaronGoodman33 \n\nThe DM was pure optics- nothing productive came out of it. @Optum took the weekend off, while our patients with cancer stayed in a limbo about whether their necessary treatment would be approved or not. https://t.co/WtFwkcYCg1", "lang": "en", "id": "1599826784786477057"}, {"entities": {"urls": [{"start": 131, "end": 154, "url": "https://t.co/lZqeaSsSto", "expanded_url": "https://tinyurl.com/542c5wx3", "display_url": "tinyurl.com/542c5wx3", "unwound_url": "https://bu.silkroad.com/epostings/index.cfm?fuseaction=app.jobinfo&id=23&jobid=311032&company_id=15509&version=1&source=ONLINE&JobOwner=1016383&level=levelid2&levelid2=20820&startflag=3"}, {"start": 255, "end": 278, "url": "https://t.co/ReQtvLr9PM", "expanded_url": "https://tinyurl.com/2p8xwczn", "display_url": "tinyurl.com/2p8xwczn", "unwound_url": "https://bu.silkroad.com/epostings/index.cfm?fuseaction=app.jobinfo&id=23&jobid=310918&company_id=15509&version=1&source=ONLINE&JobOwner=1016383&level=levelid2&levelid2=20820&startflag=3"}], "annotations": [{"start": 60, "end": 65, "probability": 0.9762, "type": "Place", "normalized_text": "Boston"}]}, "author_id": "1578929666", "edit_history_tweet_ids": ["1599787532568252422"], "created_at": "2022-12-05T15:27:25.000Z", "conversation_id": "1599787532568252422", "text": "Looking for an A+  hematology clinician investigator job in Boston?  We would love to hear from you. Graduating fellows welcome. \n\nhttps://t.co/lZqeaSsSto\n\n For residents considering heme/onc fellowship, our section needs hospitalists!  Great mentoring \n\nhttps://t.co/ReQtvLr9PM", "lang": "en", "id": "1599787532568252422"}, {"author_id": "1126106500701806592", "referenced_tweets": [{"type": "replied_to", "id": "1599557478538043394"}], "edit_history_tweet_ids": ["1599578871611158530"], "created_at": "2022-12-05T01:38:16.000Z", "conversation_id": "1599557478538043394", "in_reply_to_user_id": "854692626015993857", "entities": {"mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "text": "@AaronGoodman33 Let us know how it is once you\u2019re done! I\u2019ve been wanting to read it", "lang": "en", "id": "1599578871611158530"}, {"author_id": "1194962714", "referenced_tweets": [{"type": "replied_to", "id": "1599557478538043394"}], "edit_history_tweet_ids": ["1599560167322181632"], "created_at": "2022-12-05T00:23:56.000Z", "conversation_id": "1599557478538043394", "in_reply_to_user_id": "854692626015993857", "entities": {"mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "text": "@AaronGoodman33 I take responsibility for recommending it. I love the book. And if people disagree i am happy to debate them.", "lang": "en", "id": "1599560167322181632"}, {"entities": {"urls": [{"start": 217, "end": 240, "url": "https://t.co/lY1whIeggs", "expanded_url": "https://www.targetedonc.com/view/clinical-commentary-dose-reduction-of-selinexor-in-relapsed-patients-with-multiple-myeloma", "display_url": "targetedonc.com/view/clinical-\u2026", "images": [{"url": "https://pbs.twimg.com/news_img/1599161806685147138/e_rIthTy?format=jpg&name=orig", "width": 480, "height": 270}, {"url": "https://pbs.twimg.com/news_img/1599161806685147138/e_rIthTy?format=jpg&name=150x150", "width": 150, "height": 150}], "status": 200, "title": "Clinical Commentary: Dose Reduction of Selinexor in Relapsed Patients With Multiple Myeloma", "description": "At a live virtual event, Sumit Madan, MD, broke down the use of quadruplet therapies in the frontline setting for patients with multiple myeloma and how to care for patients when they relapse on treatment.", "unwound_url": "https://www.targetedonc.com/view/clinical-commentary-dose-reduction-of-selinexor-in-relapsed-patients-with-multiple-myeloma"}], "annotations": [{"start": 186, "end": 195, "probability": 0.7822, "type": "Other", "normalized_text": "Karyopharm"}], "mentions": [{"start": 96, "end": 108, "username": "TargetedOnc", "id": "726304448"}]}, "author_id": "1269642863924609025", "edit_history_tweet_ids": ["1599445097224892418"], "created_at": "2022-12-04T16:46:42.000Z", "conversation_id": "1599445097224892418", "text": "Is it fair for us to politely ask (without disrespecting the people being interviewed) who pays @TargetedOnc for this content?\n\nIs it fair to ask them to report money they received from Karyopharm (if any) for this?\n\nhttps://t.co/lY1whIeggs", "lang": "en", "id": "1599445097224892418"}, {"author_id": "913851074", "referenced_tweets": [{"type": "replied_to", "id": "1599057168103538690"}], "edit_history_tweet_ids": ["1599416272323690496"], "created_at": "2022-12-04T14:52:09.000Z", "conversation_id": "1599057168103538690", "entities": {"annotations": [{"start": 16, "end": 22, "probability": 0.5332, "type": "Other", "normalized_text": "myeloma"}, {"start": 212, "end": 221, "probability": 0.6271, "type": "Other", "normalized_text": "Karyopharm"}], "mentions": [{"start": 0, "end": 9, "username": "ManniMD1", "id": "1269642863924609025"}]}, "in_reply_to_user_id": "1269642863924609025", "text": "@ManniMD1 I'm a myeloma coach and humble student of this complex disease, but why would anyone who is only intermediate risk smoldering subject themselves to the potential side effects of this drug?? Only serves Karyopharm's interest in increasing market share.", "lang": "en", "id": "1599416272323690496"}, {"author_id": "2417458314", "edit_history_tweet_ids": ["1599219692559745024"], "created_at": "2022-12-04T01:51:01.000Z", "conversation_id": "1599219692559745024", "entities": {"annotations": [{"start": 6, "end": 21, "probability": 0.3438, "type": "Other", "normalized_text": "Chicago Leukemia"}, {"start": 23, "end": 29, "probability": 0.5868, "type": "Other", "normalized_text": "myeloid"}, {"start": 39, "end": 45, "probability": 0.8731, "type": "Other", "normalized_text": "Twitter"}], "mentions": [{"start": 94, "end": 107, "username": "UChicagoLeuk", "id": "1599205265928224768"}, {"start": 109, "end": 122, "username": "myeloidmalig", "id": "433627422"}, {"start": 123, "end": 137, "username": "AyaOncologist", "id": "1189289857845088256"}, {"start": 138, "end": 148, "username": "michaelwd", "id": "10056172"}, {"start": 150, "end": 162, "username": "CanerSaygin", "id": "2234768227"}, {"start": 163, "end": 174, "username": "RoloffGreg", "id": "1268610580740550656"}, {"start": 175, "end": 191, "username": "HowellJollyBody", "id": "603145861"}, {"start": 192, "end": 203, "username": "mariamtn89", "id": "1362922953076334592"}, {"start": 204, "end": 213, "username": "gvencut1", "id": "908519925672792064"}]}, "text": "The U Chicago Leukemia/myeloid program Twitter account is up and running! Give it a follow at @UChicagoLeuk\n\n@myeloidmalig @AyaOncologist @michaelwd  @CanerSaygin @RoloffGreg @HowellJollyBody @mariamtn89 @gvencut1", "lang": "en", "id": "1599219692559745024"}, {"entities": {"urls": [{"start": 188, "end": 211, "url": "https://t.co/KiX8sHXVJy", "expanded_url": "https://twitter.com/VPrasadMDMPH/status/1599126088411541504", "display_url": "twitter.com/VPrasadMDMPH/s\u2026"}], "annotations": [{"start": 92, "end": 98, "probability": 0.5821, "type": "Other", "normalized_text": "myeloma"}, {"start": 118, "end": 124, "probability": 0.9812, "type": "Other", "normalized_text": "Twitter"}]}, "author_id": "1194962714", "referenced_tweets": [{"type": "quoted", "id": "1599126088411541504"}], "edit_history_tweet_ids": ["1599210886518173697"], "created_at": "2022-12-04T01:16:01.000Z", "conversation_id": "1599210886518173697", "text": "The fact 20,000 people are tuning into a discussion on whether we ought to treat smoldering myeloma is incredible. \ud83d\udc47\ud83d\udc47 Twitter is really a powerful force. I hope it continues to improve :) https://t.co/KiX8sHXVJy", "lang": "en", "id": "1599210886518173697"}, {"author_id": "18792477", "referenced_tweets": [{"type": "replied_to", "id": "1599192787391778820"}], "edit_history_tweet_ids": ["1599207509738209280"], "created_at": "2022-12-04T01:02:36.000Z", "conversation_id": "1599142217792516096", "in_reply_to_user_id": "854692626015993857", "entities": {"mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 16, "end": 29, "username": "BrownHospMed", "id": "1493597471074832393"}]}, "text": "@AaronGoodman33 @BrownHospMed You need a better conditioner", "lang": "en", "id": "1599207509738209280"}, {"author_id": "1117857169528033280", "referenced_tweets": [{"type": "replied_to", "id": "1599192787391778820"}], "edit_history_tweet_ids": ["1599193443711930369"], "created_at": "2022-12-04T00:06:43.000Z", "conversation_id": "1599142217792516096", "in_reply_to_user_id": "854692626015993857", "entities": {"mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 16, "end": 29, "username": "BrownHospMed", "id": "1493597471074832393"}]}, "text": "@AaronGoodman33 @BrownHospMed Thats a variant.", "lang": "en", "id": "1599193443711930369"}, {"entities": {"urls": [{"start": 261, "end": 284, "url": "https://t.co/cDE8Os23wh", "expanded_url": "https://twitter.com/BrownHospMed/status/1599142217792516096/photo/1", "display_url": "pic.twitter.com/cDE8Os23wh", "media_key": "3_1599142212830466049"}], "annotations": [{"start": 183, "end": 198, "probability": 0.7288, "type": "Other", "normalized_text": "thrombocytopenia"}, {"start": 204, "end": 216, "probability": 0.6873, "type": "Other", "normalized_text": "lymphocytosis"}, {"start": 250, "end": 259, "probability": 0.4527, "type": "Other", "normalized_text": "Medtwitter"}], "hashtags": [{"start": 249, "end": 260, "tag": "Medtwitter"}]}, "author_id": "1493597471074832393", "edit_history_tweet_ids": ["1599142217792516096"], "created_at": "2022-12-03T20:43:10.000Z", "conversation_id": "1599142217792516096", "text": "A 60-year-old man presented with a 6-month history of fatigue, weight loss, and gingival bleeding. Physical examination suggested the presence of a massively enlarged spleen. Labs w/ thrombocytopenia and lymphocytosis. What is the likely diagnosis? #Medtwitter https://t.co/cDE8Os23wh", "lang": "en", "id": "1599142217792516096"}, {"entities": {"urls": [{"start": 40, "end": 63, "url": "https://t.co/eqgQ6iPtPd", "expanded_url": "https://twitter.com/VPrasadMDMPH/status/1599126088411541504", "display_url": "twitter.com/VPrasadMDMPH/s\u2026"}], "mentions": [{"start": 22, "end": 38, "username": "Plenary_Session", "id": "1028063001755103233"}]}, "author_id": "1028063001755103233", "referenced_tweets": [{"type": "quoted", "id": "1599126088411541504"}], "edit_history_tweet_ids": ["1599137975329492992"], "created_at": "2022-12-03T20:26:18.000Z", "conversation_id": "1599137975329492992", "text": "Now on the audio feed @Plenary_Session! https://t.co/eqgQ6iPtPd", "lang": "en", "id": "1599137975329492992"}, {"entities": {"urls": [{"start": 20, "end": 43, "url": "https://t.co/3Dz9YDwTVC", "expanded_url": "https://twitter.com/VPrasadMDMPH/status/1599126088411541504", "display_url": "twitter.com/VPrasadMDMPH/s\u2026"}], "annotations": [{"start": 11, "end": 17, "probability": 0.9772, "type": "Other", "normalized_text": "Twitter"}]}, "author_id": "461579451", "referenced_tweets": [{"type": "quoted", "id": "1599126088411541504"}], "edit_history_tweet_ids": ["1599145203348082689"], "created_at": "2022-12-03T20:55:01.000Z", "conversation_id": "1599145203348082689", "text": "Why I love Twitter\u2026 https://t.co/3Dz9YDwTVC", "lang": "en", "id": "1599145203348082689"}, {"entities": {"urls": [{"start": 108, "end": 131, "url": "https://t.co/sdrdvtEjvK", "expanded_url": "https://twitter.com/VPrasadMDMPH/status/1599126088411541504", "display_url": "twitter.com/VPrasadMDMPH/s\u2026"}], "annotations": [{"start": 33, "end": 37, "probability": 0.7528, "type": "Other", "normalized_text": "Vinay"}, {"start": 67, "end": 73, "probability": 0.9881, "type": "Other", "normalized_text": "Twitter"}]}, "author_id": "1472332068914962433", "referenced_tweets": [{"type": "quoted", "id": "1599126088411541504"}], "edit_history_tweet_ids": ["1599169972072169472"], "created_at": "2022-12-03T22:33:27.000Z", "conversation_id": "1599169972072169472", "text": "Wow! Great new video series from Vinay !\nI enjoyed it a lot !\n\nMed Twitter is alive, for sure !\nWell done \ud83d\udc4f https://t.co/sdrdvtEjvK", "lang": "en", "id": "1599169972072169472"}, {"author_id": "1068352638499020800", "edit_history_tweet_ids": ["1599082579202027521"], "created_at": "2022-12-03T16:46:11.000Z", "conversation_id": "1599082579202027521", "entities": {"annotations": [{"start": 53, "end": 75, "probability": 0.649, "type": "Other", "normalized_text": "Breast Medical Oncology"}], "mentions": [{"start": 82, "end": 93, "username": "UCSDCancer", "id": "1473383250995281922"}]}, "text": "We are hiring!!! We are looking to add to our lovely Breast Medical Oncology Team @UCSDCancer if you are interested please let me know!", "lang": "en", "id": "1599082579202027521"}, {"entities": {"urls": [{"start": 151, "end": 174, "url": "https://t.co/aZBkb3BvVp", "expanded_url": "https://twitter.com/Plenary_Session/status/1599138243228073985/photo/1", "display_url": "pic.twitter.com/aZBkb3BvVp", "media_key": "3_1599138043855708160"}], "mentions": [{"start": 137, "end": 150, "username": "VPrasadMDMPH", "id": "1194962714"}]}, "author_id": "1028063001755103233", "edit_history_tweet_ids": ["1599138243228073985"], "created_at": "2022-12-03T20:27:22.000Z", "conversation_id": "1599138243228073985", "text": "Plenary Session Downloads are Insane\nMillions of downloads &amp; growing\nMost Popular Heme Onc Podcast Globally\nThanks to the listeners!\n@VPrasadMDMPH https://t.co/aZBkb3BvVp", "lang": "en", "id": "1599138243228073985"}, {"entities": {"urls": [{"start": 272, "end": 295, "url": "https://t.co/MhLvKAXP29", "expanded_url": "https://twitter.com/VPrasadMDMPH/status/1599126088411541504/video/1", "display_url": "pic.twitter.com/MhLvKAXP29", "media_key": "7_1599123197223280641"}], "annotations": [{"start": 2, "end": 8, "probability": 0.9727, "type": "Other", "normalized_text": "Twitter"}, {"start": 48, "end": 54, "probability": 0.5988, "type": "Other", "normalized_text": "Myeloma"}, {"start": 134, "end": 138, "probability": 0.727, "type": "Other", "normalized_text": "ASH22"}, {"start": 170, "end": 176, "probability": 0.967, "type": "Other", "normalized_text": "Youtube"}], "mentions": [{"start": 211, "end": 227, "username": "Plenary_Session", "id": "1028063001755103233"}, {"start": 228, "end": 243, "username": "AaronGoodman33", "id": "854692626015993857"}], "hashtags": [{"start": 133, "end": 139, "tag": "ASH22"}]}, "author_id": "1194962714", "edit_history_tweet_ids": ["1599126088411541504"], "created_at": "2022-12-03T19:39:04.000Z", "conversation_id": "1599126088411541504", "text": "A Twitter Battle on Treating HR Risk Smoldering Myeloma\nI break down the debate and arguments\nA 3 part video series just in time for #ASH22\n(a clearer video uploading to Youtube, will post link at end of video)\n@Plenary_Session @AaronGoodman33 \nPART 1 - The battle starts https://t.co/MhLvKAXP29", "lang": "en", "id": "1599126088411541504"}, {"entities": {"urls": [{"start": 279, "end": 302, "url": "https://t.co/sRtYz7WxIi", "expanded_url": "https://twitter.com/aarongoodman33/status/1598826846082121728", "display_url": "twitter.com/aarongoodman33\u2026"}], "annotations": [{"start": 31, "end": 35, "probability": 0.5531, "type": "Other", "normalized_text": "HRSMM"}, {"start": 104, "end": 106, "probability": 0.4639, "type": "Other", "normalized_text": "SMM"}]}, "author_id": "28731834", "referenced_tweets": [{"type": "quoted", "id": "1598826846082121728"}], "edit_history_tweet_ids": ["1599115678836924416"], "created_at": "2022-12-03T18:57:42.000Z", "conversation_id": "1599115678836924416", "text": "No one is forcing you to treat HRSMM. An expert in the field presented  his reasoning. I don\u2019t treat HR SMM-stop with the patriarchal approach to Medicine. \nDiscuss data with the patient and let them make a decision. Every day is a rant on why  someone else\u2019s approach is wrong. https://t.co/sRtYz7WxIi", "lang": "en", "id": "1599115678836924416"}, {"author_id": "1294745239656202240", "referenced_tweets": [{"type": "replied_to", "id": "1599107232825999360"}], "edit_history_tweet_ids": ["1599110786210676736"], "created_at": "2022-12-03T18:38:16.000Z", "conversation_id": "1598826846082121728", "entities": {"annotations": [{"start": 86, "end": 92, "probability": 0.9222, "type": "Organization", "normalized_text": "Nirvana"}, {"start": 155, "end": 161, "probability": 0.9826, "type": "Organization", "normalized_text": "Beatles"}, {"start": 164, "end": 169, "probability": 0.8985, "type": "Organization", "normalized_text": "Eagles"}, {"start": 179, "end": 188, "probability": 0.7441, "type": "Organization", "normalized_text": "Yatch Rock"}], "mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 16, "end": 28, "username": "chadinabhan", "id": "2212735524"}]}, "in_reply_to_user_id": "854692626015993857", "text": "@AaronGoodman33 @chadinabhan I would never say that blafesmy.\nBut I must point out my Nirvana superfan days are long gone. \nToday Im an old man, who likes Beatles, Eagles and all Yatch Rock bands...", "lang": "en", "id": "1599110786210676736"}, {"entities": {"urls": [{"start": 167, "end": 190, "url": "https://t.co/zLRE7dZG5A", "expanded_url": "https://twitter.com/Sthanu5/status/1599106602958999552/photo/1", "display_url": "pic.twitter.com/zLRE7dZG5A", "media_key": "3_1599106598076444672"}], "annotations": [{"start": 16, "end": 44, "probability": 0.84, "type": "Other", "normalized_text": "Chronic Granulomatous Disease"}, {"start": 94, "end": 105, "probability": 0.4637, "type": "Other", "normalized_text": "dinucleotide"}, {"start": 118, "end": 122, "probability": 0.6777, "type": "Other", "normalized_text": "NADPH"}, {"start": 125, "end": 131, "probability": 0.5506, "type": "Other", "normalized_text": "oxidase"}, {"start": 134, "end": 165, "probability": 0.5706, "type": "Other", "normalized_text": "Nitroblue tetrazolium blood test"}], "mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "author_id": "821765042051784705", "referenced_tweets": [{"type": "replied_to", "id": "1599096602895200256"}], "edit_history_tweet_ids": ["1599106602958999552"], "created_at": "2022-12-03T18:21:38.000Z", "conversation_id": "1599096602895200256", "in_reply_to_user_id": "854692626015993857", "text": "@AaronGoodman33 Chronic Granulomatous Disease\n\ndefective function of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase\n\nNitroblue tetrazolium blood test https://t.co/zLRE7dZG5A", "lang": "en", "id": "1599106602958999552"}, {"entities": {"urls": [{"start": 278, "end": 301, "url": "https://t.co/F7GUXBE9Th", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599095143818473472", "display_url": "twitter.com/AaronGoodman33\u2026"}], "annotations": [{"start": 52, "end": 61, "probability": 0.5572, "type": "Other", "normalized_text": "E. Paietta"}, {"start": 65, "end": 69, "probability": 0.6797, "type": "Other", "normalized_text": "Z.Sun"}], "mentions": [{"start": 12, "end": 21, "username": "MRLitzow", "id": "973216285"}, {"start": 22, "end": 36, "username": "SelinaLugerMD", "id": "4827569945"}, {"start": 37, "end": 51, "username": "MartinTallman", "id": "1334487799718961153"}, {"start": 89, "end": 95, "username": "eaonc", "id": "2201478360"}, {"start": 249, "end": 260, "username": "CMullighan", "id": "1579638991"}], "hashtags": [{"start": 271, "end": 277, "tag": "ASH22"}]}, "author_id": "3076847052", "referenced_tweets": [{"type": "quoted", "id": "1599095143818473472"}], "edit_history_tweet_ids": ["1599115085322285056"], "created_at": "2022-12-03T18:55:21.000Z", "conversation_id": "1599115085322285056", "text": "Congrats to @MRLitzow @SelinaLugerMD @MartinTallman E. Paietta , Z.Sun &amp; the rest of @eaonc team! This trial is one that keeps on giving, including \ud83d\udc4c\ud83c\udffbknowledge on the biology of B-ALL also from samples collected from pts on this trial thanks to @CMullighan and team. #ASH22 https://t.co/F7GUXBE9Th", "lang": "en", "id": "1599115085322285056"}, {"entities": {"urls": [{"start": 273, "end": 296, "url": "https://t.co/0H8zHvXm1d", "expanded_url": "https://twitter.com/AaronGoodman33/status/1599093726345056256", "display_url": "twitter.com/AaronGoodman33\u2026"}], "annotations": [{"start": 39, "end": 45, "probability": 0.6737, "type": "Other", "normalized_text": "myeloma"}, {"start": 48, "end": 51, "probability": 0.5389, "type": "Other", "normalized_text": "mmsm"}, {"start": 241, "end": 247, "probability": 0.5082, "type": "Other", "normalized_text": "myeloma"}], "hashtags": [{"start": 47, "end": 52, "tag": "mmsm"}]}, "author_id": "774267564", "referenced_tweets": [{"type": "quoted", "id": "1599093726345056256"}], "edit_history_tweet_ids": ["1599105106867212288"], "created_at": "2022-12-03T18:15:42.000Z", "conversation_id": "1599105106867212288", "text": "This study should be our role model in myeloma #mmsm \n\u2705amending protocol to give a new standard of care proven to be helpful after starting study\n\u2705Not complaining about it (doing whats best for pts)\n\u2705doing this in a disease less common than myeloma\nAnd excellent results \ud83d\udc47 https://t.co/0H8zHvXm1d", "lang": "en", "id": "1599105106867212288"}, {"author_id": "2212735524", "referenced_tweets": [{"type": "replied_to", "id": "1599096718997737472"}], "edit_history_tweet_ids": ["1599103860546555905"], "created_at": "2022-12-03T18:10:44.000Z", "conversation_id": "1598826846082121728", "in_reply_to_user_id": "854692626015993857", "entities": {"mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 16, "end": 28, "username": "GuiperiniMD", "id": "1294745239656202240"}]}, "text": "@AaronGoodman33 @GuiperiniMD Can I be there in case the exchange turns violent?", "lang": "en", "id": "1599103860546555905"}, {"author_id": "709569412370534400", "referenced_tweets": [{"type": "replied_to", "id": "1599096602895200256"}], "edit_history_tweet_ids": ["1599100472157011969"], "created_at": "2022-12-03T17:57:17.000Z", "conversation_id": "1599096602895200256", "entities": {"annotations": [{"start": 74, "end": 82, "probability": 0.8426, "type": "Other", "normalized_text": "wikimedia"}], "mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "in_reply_to_user_id": "854692626015993857", "text": "@AaronGoodman33 Ha ha this looks exactly like a granuloma pic I posted on wikimedia commons \ud83d\udd25\ud83d\udd25\ud83d\udd25", "lang": "en", "id": "1599100472157011969"}, {"author_id": "68671526", "referenced_tweets": [{"type": "replied_to", "id": "1599093726345056256"}], "edit_history_tweet_ids": ["1599096928729321472"], "created_at": "2022-12-03T17:43:12.000Z", "conversation_id": "1599093726345056256", "entities": {"annotations": [{"start": 136, "end": 144, "probability": 0.5259, "type": "Other", "normalized_text": "Ewall-INO"}, {"start": 221, "end": 228, "probability": 0.6325, "type": "Other", "normalized_text": "miniHCVD"}, {"start": 230, "end": 239, "probability": 0.7228, "type": "Other", "normalized_text": "Venetoclax"}], "mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 16, "end": 30, "username": "MartinTallman", "id": "1334487799718961153"}]}, "in_reply_to_user_id": "854692626015993857", "text": "@AaronGoodman33 @MartinTallman Is there a particular regimen that are you using for older patients with B or T ALL? For a moment we had Ewall-INO for B-ALL, but out protocol patients are very challenging (for T-ALL maybe miniHCVD+Venetoclax - ASH2021?)", "lang": "en", "id": "1599096928729321472"}, {"author_id": "1343430777321582593", "referenced_tweets": [{"type": "replied_to", "id": "1599096602895200256"}], "edit_history_tweet_ids": ["1599097093788164097"], "created_at": "2022-12-03T17:43:51.000Z", "conversation_id": "1599096602895200256", "entities": {"annotations": [{"start": 16, "end": 41, "probability": 0.7007, "type": "Other", "normalized_text": "Nitroblue tetrazolium test"}], "mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "in_reply_to_user_id": "854692626015993857", "text": "@AaronGoodman33 Nitroblue tetrazolium test --&gt; some brick red colouration", "lang": "en", "id": "1599097093788164097"}, {"author_id": "782764410", "referenced_tweets": [{"type": "replied_to", "id": "1599093726345056256"}], "edit_history_tweet_ids": ["1599096396153425920"], "created_at": "2022-12-03T17:41:05.000Z", "conversation_id": "1599093726345056256", "entities": {"annotations": [{"start": 65, "end": 69, "probability": 0.535, "type": "Other", "normalized_text": "Ph- B"}, {"start": 173, "end": 175, "probability": 0.7004, "type": "Other", "normalized_text": "MRD"}, {"start": 191, "end": 198, "probability": 0.6677, "type": "Other", "normalized_text": "clonoseq"}, {"start": 266, "end": 270, "probability": 0.6998, "type": "Other", "normalized_text": "blina"}], "mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}, {"start": 16, "end": 30, "username": "MartinTallman", "id": "1334487799718961153"}]}, "in_reply_to_user_id": "854692626015993857", "text": "@AaronGoodman33 @MartinTallman Definitely practice changing. For Ph- B-ALL these data are QUITE impressive as far as OS that far out.\n\nI do wonder if using a more sensitive MRD panel such as clonoseq (given the more than 0.01% sensitivity) has an impact on need for blina in all settings", "lang": "en", "id": "1599096396153425920"}, {"author_id": "1294745239656202240", "referenced_tweets": [{"type": "replied_to", "id": "1599094082814775296"}], "edit_history_tweet_ids": ["1599094706910003200"], "created_at": "2022-12-03T17:34:22.000Z", "conversation_id": "1598826846082121728", "entities": {"annotations": [{"start": 81, "end": 84, "probability": 0.643, "type": "Other", "normalized_text": "NoLa"}, {"start": 112, "end": 118, "probability": 0.4181, "type": "Organization", "normalized_text": "Nirvana"}], "mentions": [{"start": 0, "end": 15, "username": "AaronGoodman33", "id": "854692626015993857"}]}, "in_reply_to_user_id": "854692626015993857", "text": "@AaronGoodman33 Relax dude.\nYou dont annoy me.\nYou can actually buy me a beer in NoLa and I will teach you some Nirvana facts.", "lang": "en", "id": "1599094706910003200"}]}, "errors": [{"value": "1599440890803630081", "detail": "Could not find tweet with referenced_tweets.id: [1599440890803630081].", "title": "Not Found Error", "resource_type": "tweet", "parameter": "referenced_tweets.id", "resource_id": "1599440890803630081", "type": "https://api.twitter.com/2/problems/resource-not-found"}], "meta": {"result_count": 100, "newest_id": "1601314763203829761", "oldest_id": "1599096602895200256", "next_token": "7140dibdnow9c7btw424ch42ha8im2oeojn3dg0pwwegm"}, "neighbors": ["1194962714", "1269642863924609025", "2212735524", "854692626015993857", "1331336294828437504", "1334487799718961153", "824315782947631104", "999010996034338818"]}